Finex logo
Finex Intelligence

Market Signal Briefing

Real-time pulse of financial headlines curated from 2 premium feeds.

Last news saved at Dec 17, 08:38 15m ago Cron last ran Dec 17, 08:38 16m ago 2 sources live
Switch language
41,965 Stories ingested Auto-fetched market intel nonstop.
450 Distinct tickers Symbols referenced across the feed
stockne... Trending sources stocknewsapi • cryptonews
Hot tickers
BTC XRP SOL DOGE ETH F
Surfacing from current coverage
Details Saved Published Title Source Tickers
2025-10-20 12:47 1mo ago
2025-10-20 08:15 1mo ago
XRP Ledger Stays Strong as Major AWS Outage Highlights Internet Fragility cryptonews
XRP
Early Monday, a major AWS outage in the US-EAST-1 region caused service disruptions across the internet. Popular platforms like ChatGPT, Reddit, Fortnite, Coinbase, and even Amazon itself faced downtime. 

Yet, the XRP Ledger (XRPL) kept closing blocks as usual and the crypto community is noticing.

Millions Disrupted as AWS Goes DownAWS reported “increased error rates and latencies for multiple AWS Services” starting at 3:11 a.m. ET. The problem, linked to DNS resolution issues with the DynamoDB API, spread to other services. By 5:27 a.m. ET, AWS had begun recovery, though backlogs meant some services would take longer to stabilize.

For companies relying on cloud infrastructure, the incident is a stark reminder that a single outage can affect millions of users and thousands of services. Convenience comes at a cost.

Read More: China’s Cyberattack Claim, AWS Outage Rock the Internet – Coinbase Among Platforms Hit

Crypto exchange Coinbase, which runs on AWS, was also briefly hit. Users faced login issues and transaction delays before the company confirmed that “all funds are safe.” Coinbase later said systems were stabilizing and services were coming back online.

Update: we're seeing early signs of recovery, with some users being able to access and use Coinbase services now.

Our team is still working on this issue with top priority. We will continue to provide updates as the situation changes.

— Coinbase Support (@CoinbaseSupport) October 20, 2025 XRPL: A Network That Doesn’t StopAmid the disruption, XRPL’s performance stood out. As crypto commentator @Vet_X0 tweeted:

“Despite AWS having issues, the XRP Ledger is closing blocks normally. That’s the hard work of decentralization, especially geographical and hosting wise. Though I believe we can do much better and increase resilience – XLS 50 is important for this transparency to drive action.”

Unlike other platforms tied closely to AWS, XRPL validators are spread across multiple cloud providers and physical locations. This distribution protects the network from outages at any single provider. 

Historical data backs this up: even a February 2025 temporary halt was resolved quickly.

How XRPL Stays Strong When Others StallThe outage highlights why XRPL’s validator network is built this way. Too many validators on one cloud provider can risk halting consensus. XLS 50 encourages transparency and better practices: validators now consider physical location, network (ASN), and cloud provider diversity.

XRPL moved forward while much of the internet paused.

What the Crypto Industry Can LearnFor crypto platforms and investors, XRPL is a lesson in resilience. Centralized cloud services are convenient but fragile. XRPL’s structure proves that careful network design and distribution can protect against large-scale outages.

In a world where one cloud failure can ripple across millions of users, XRP Ledger is setting the bar: decentralized networks can, and do, work better.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-10-20 12:47 1mo ago
2025-10-20 08:15 1mo ago
Strategy Expands Bitcoin Holdings to 640,418 BTC With Latest Purchase cryptonews
BTC
The company financed the acquisition by raising $18.8 million through the issuance of various perpetual preferred shares and common stockUpdated Oct 20, 2025, 12:23 p.m. Published Oct 20, 2025, 12:15 p.m.

Strategy (MSTR), the largest publicly traded corporate holder of bitcoin, purchased 168 BTC at an average price of $112,051, according to a filing on Monday.

The company financed the acquisition by raising $18.8 million through the issuance of various perpetual preferred shares and common stock.

This latest purchase brings MSTR’s total bitcoin holdings to 640,418 BTC ($71 billion), with an overall average acquisition price of around $74,010.

BTC climbed to over $115,000 on Oct. 13 but fell as low as $103,500 on Oct. 17.

Bitcoin’s has seen a recent rebound to $111,000 on Monday, helping MSTR shares to a 3% gain in pre-market trading, just below $300 per share. However, the stock remains negative on a year-to-date basis, compared to bitcoin's 19% gain.

The MSTR/BlackRock iShares Trust (IBIT) ratio currently stands at 4.74, its lowest level since October 2024. This highlights how the IBIT ETF has outperformed MSTR over the past 12 months, as the ratio previously hit an all-time high of 8.0 in November 2024.

MSTR/IBIT Ratio (TradingView)

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent.

View Full Report

More For You

Wall Street Bank Citi Sees Stablecoins Powering Crypto’s Next Growth Phase

Stablecoins are growing alongside crypto, lifting Ethereum while new networks loom and the dollar stays dominant.

What to know:

Stablecoins are still largely used as an entry point to crypto, with little effect on overall bank deposits but potential pressure on funding costs, the report said.Ethereum benefits from the boom, but Citi warned new networks could erode the blockchain's dominance as dollar-backed coins continue to lead.Read full story
2025-10-20 12:47 1mo ago
2025-10-20 08:18 1mo ago
Dogecoin Founder Sounds Unusual Alarm on Avalanche cryptonews
AVAX DOGE
Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Avalanche (AVAX) is finally gaining attention on the crypto market following a new shoutout from Dogecoin cofounder Billy Markus. The crypto X personality revealed a new ranking that placed Avalanche ahead of unnamed rivals in the Web3 ecosystem. It is worth noting that this comment comes as AVAX has been gaining new attention on the social scene in the past few months.

Avalanche ranked number 1 on crypto listBilly Markus is known as a cryptic, fun crypto personality, whose conversations are rarely an endorsement beyond Bitcoin and Dogecoin. In the X post, he said there are the top 5 cryptocurrencies giving points for posting about the crypto.

However, the Dogecoin founder, known as Shibetoshi Nakamoto, acknowledged that he does not "know what the points do" despite having the opportunity to acquire those points.

For the list of projects that fall in this group, Avalanche leads. The crypto ranking, however, pooled no known project in 2nd to 5th place.

top 5 cryptos giving points for posting about the crypto and i don’t know what the points do but you can get points:

1) avax 🔺
2-5) 🤷‍♂️

— Shibetoshi Nakamoto (@BillyM2k) October 20, 2025 As a way to connect with the community, Avalanche has a reward scheme for engaging with content-promoting projects. This initiative has gained traction in recent times, with tokens like $BELLS and MANYU benefiting from it.

Avalanche was once a major crypto on the market, with AVAX whale transactions known to dominate the ecosystem. However, the competition in the industry grew bigger, with newer projects like Hyperliquid taking center stage.

Despite the innovative technology that the Avalanche protocol brandishes, it needs a community-driven boost that is just playing out.

AVAX price and market revaluationSince the Avalanche9000 protocol upgrade from earlier in the year, there has been a huge expectation for the AVAX price to break new highs. At press time, the layer-1 protocol was changing hands for $20.82, up 2.35% in the past 24 hours.

Over time, Avalanche has been displaced by other protocols, and it currently ranks as the 17th largest digital currency with a market cap of $8.891 billion. It is now below its major peers, including Solana and Cardano, in the top asset rankings.

The Dogecoin cofounder’s shoutout lends credence to how Avalanche remains a major player in the ecosystem. In recognition of its uniqueness, Grayscale Investments launched a trust for AVAX over a year ago.

This move has increased the likelihood of the coin receiving approval for a spot exchange-traded fund (ETF) product as the market adjusts to the new U.S. SEC regime.
2025-10-20 12:47 1mo ago
2025-10-20 08:18 1mo ago
Chainlink price eyes $25 as $116.7M LINK token leaves Binance cryptonews
LINK
Chainlink price is forming a bullish reversal pattern, with a potential upside target near $25 as onchain data suggests accumulation by new wallets.

Summary

Chainlink price may have formed a double bottom between $15.00–$15.70, indicating waning selling pressure.
A move above the $20 neckline, especially with an RSI breakout, could trigger a measured rally toward $25–$26.
Since October 10, 30 new wallets have withdrawn over 6.25M LINK from Binance, adding support for the bullish case.

Chainlink (LINK) price remains in a medium-term downtrend, with the price having recently extended its move beneath the descending trendline following the October 10 sell-off, when the market faced widespread liquidations amid rising trade tensions. On that day, LINK plunged over 20%.

However, there are emerging signs that bearish momentum may be waning. Chainlink price appears to have formed a potential double bottom in the $15.00–$15.70 region — with the first low established during the October 10 crash and the second developing after a brief recovery and subsequent pullback. This pattern suggests that selling pressure is subsiding as buyers begin to defend a key support level.

The neckline of this potential reversal pattern lies around the $20.00 mark, which, if broken, would activate a measured move target near $25.00–$26.00. If a breakout above the neckline coincides with an RSI break through its own descending trendline resistance, it would significantly strengthen the bullish case.

Source: TradingView
New wallets stack Chainlink
Adding further weight to cautiously bullish technicals, on-chain data shows significant accumulation by new wallets. According to Lookonchain, since October 11, 30 new wallets have withdrawn a total of 6,256,893 LINK ($116.7M) from Binance.

This activity suggests that investors are moving large amounts into private wallets for holding rather than active trading. Such accumulation could provide additional support if Chainlink price approaches the $20 neckline, reinforcing the potential for a sustained rally toward the $25–$26 target.

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.
2025-10-20 12:47 1mo ago
2025-10-20 08:21 1mo ago
New Monday, New Bitcoin Purchase: Strategy Increases Its Holdings to 640,418 BTC cryptonews
BTC
The company sits on a massive paper profit of almost $24 billion due to its investment in BTC.

Strategy, the software company formerly known as MicroStrategy, has established a tradition of announcing Bitcoin purchases at the start of each week, and this Monday was no exception.

Michael Sayler – the devoted proponent of the primary cryptocurrency and founder of the firm – revealed on X that the entity has scooped up 168 BTC for roughly $18.8 million at an average price of $112,051 per unit. Strategy has achieved BTC Yield of 26% YTD 2025, and following the latest buy, it has increased its holdings to 640,418 BTC.

Strategy has acquired 168 BTC for ~$18.8 million at ~$112,051 per bitcoin and has achieved BTC Yield of 26.0% YTD 2025. As of 10/19/2025, we hodl 640,418 $BTC acquired for ~$47.40 billion at ~$74,010 per bitcoin. $MSTR $STRC $STRK $STRF $STRD https://t.co/UILBHXkA6a

— Michael Saylor (@saylor) October 20, 2025

The company started its BTC journey in the summer of BTC and has spent around $47.4 billion to acquire its stash. As of this writing, the USD equivalent of its crypto holdings is over $71 billion, meaning Strategy is sitting on a massive profit of almost $24 billion (at least on paper).

Meanwhile, the firm’s stocks have headed south in the past few months after peaking above $450 during the summer. Currently, MSTR is worth around $289, representing a 13% decline over the past 30 days.

Dimitar got interested in cryptocurrencies back in 2018 amid the prolonged bear market. His biggest passion in the field is Bitcoin and he was fascinated with its journey. With a flair for producing high-quality content, he started covering the cryptocurrency space in late 2018. His hobby is football.
2025-10-20 12:47 1mo ago
2025-10-20 08:24 1mo ago
BNB Climbs as Crypto Markets Rebound on Potential Fed Policy Shift cryptonews
BNB
Sentiment remains cautious, with the Crypto Fear & Greed Index at 30, indicating "fear" in the market. Oct 20, 2025, 12:24 p.m.

BNB, the native token of the BNB Chain, rose 1.4% in the last 24-hour period, despite sharp swings that saw its price move through a 7% range during a high-volume session, according to CoinDesk Research's technical analysis data model.

The gain comes amid a risk-asset rally that saw bitcoin rise 2.6% in the last 24 hours, while the wider crypto market moved up 2.5% based on the CoinDesk 20 (CD20) index after U.S. President Donald Trump softened his stance on tariffs and amid signs the Federal Reserve may ease its quantitative tightening program in the near future.

BNB opened the session near $1,077 and climbed as high as $1,144 before paring gains. The advance coincided a surge in trading volume, which spiked to 128,847 tokens, nearly double the 24-hour average.

After a dip to around $1,090, buyers stepped in again before resistance capped the move near $1,144. BNB then saw a pullback as the token slipped from $1,128 to $1,122, reflecting waning momentum.

Last week, Coinbase added the token to its list of assets under review for full platform support, part of its newly launched “Blue Carpet” initiative aimed at expanding retail access to more tokens. Around the same time, China Merchants Bank International (CMBI) tokenized its U.S. dollar money market fund on the BNB Chain, issuing two tokens — CMBMINT and CMBIMINT — for accredited investors.

Traders are pricing in a 25 basis-point interest-rate cut from the Federal Reserve this month, while signs of easing trade tensions between the U.S. and China added to risk appetite.

On the other hand, growing geopolitical tensions are weighing on risk assets. Despite the rebound, sentiment remains cautious. The Crypto Fear & Greed Index is at 30, meaning sentiment remains in the “fear” area.

Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent.

View Full Report

More For You

Strategy Expands Bitcoin Holdings to 640,418 BTC With Latest Purchase

The company financed the acquisition by raising $18.8 million through the issuance of various perpetual preferred shares and common stock

What to know:

Strategy purchased purchased 168 BTC at an average price of $112,051, bringing total holdings to 640,418 BTC.MSTR shares rise 3% in pre-market trading, trading just below $300 per share. The stock remains negative on a year-to-date basis, compared to bitcoin's 19% gain.Read full story
2025-10-20 12:47 1mo ago
2025-10-20 08:25 1mo ago
Hackers Drain $3M in XRP From US Wallet, On-Chain Sleuth ZachXBT Reveals cryptonews
XRP
TL;DR

A U.S. crypto user lost roughly $3.05 million in XRP after their Ellipal wallet was compromised.
Blockchain investigator ZachXBT traced the stolen funds through cross-chain bridges and into OTC venues linked to Huione.
The theft highlights ongoing risks in wallet security and the growing role of decentralized monitoring in tracking crypto crime, showing both the challenges and capabilities of on-chain analysis in real-time.

A U.S. individual recently suffered a major crypto loss when about $3.05 million worth of XRP was stolen from their Ellipal wallet. According to blockchain sleuth ZachXBT, the funds were rapidly moved through multiple bridges, eventually ending up in over-the-counter venues connected to Huione, a marketplace with prior allegations of laundering activity. This case also demonstrates how fast funds can move across networks before exchanges can intervene.

Detailed Tracking Shows Complex Movement
In a thread published on X on October 19, ZachXBT documented the full path of the theft. More than 120 Ripple-to-Tron swaps were identified on October 12, followed by consolidation on the Tron network. By October 15, the funds were dispersed to Huione-linked OTC channels, illustrating the speed and complexity of cross-chain laundering operations. The detailed timestamps and transaction links make it possible for analysts to reconstruct the full flow almost in real time.

Authorities have previously highlighted Huione’s involvement in large-scale laundering schemes, particularly linked to Southeast Asia. U.S. Treasury proposals earlier this year aimed at sanctioning entities associated with these flows, while FinCEN identified Huione as a significant money-laundering concern, citing billions in suspicious activity.

User Error Highlights Wallet Security Challenges
ZachXBT noted that the victim appeared inexperienced, suggesting the loss stemmed from user error rather than a technical exploit. Ellipal wallets that combine custodial and non-custodial features can confuse users, and in this case, the wallet functioned as a hot wallet despite the user assuming it was cold storage.  

This incident reflects persistent attack vectors in 2025, as highlighted in a TRM Labs report documenting over $2 billion stolen during the year’s first half through private-key thefts and wallet breaches. Many of these cases also involve cross-chain swaps and OTC cashouts, echoing the patterns traced by ZachXBT.

While recovery prospects remain low due to reporting delays and jurisdictional complications, the episode underscores the importance of vigilance in wallet usage and the emerging role of on-chain forensic analysis. XRP, the native token of the XRP Ledger, traded near $2.46 today, marking a 6% rise in the past 24 hours as the market stabilizes after recent liquidation events.
2025-10-20 12:47 1mo ago
2025-10-20 08:26 1mo ago
Ethereum price reclaims $4,000 after strong ETF outflow week cryptonews
ETH
Ethereum is back in the green despite heavy outflows from exchange-traded funds last week, signaling early signs of a price rebound.

Summary

Ethereum price has bounced back above $4,000 despite over $300 million in ETF outflows last week.
The token’s price rebounded off the $3,800 support zone and is testing key technical levels.
ETH is trading just below the 30-day EMA, with signs of declining bearish momentum. A breakout above resistance could open the door to $4,300–$4,500 in the short term.
Overall market sentiment is improving, which could attract fresh institutional inflows.

Trading around $4,037 at the time of writing, ETH has gained over 4% on the day, according to market data from crypto.news. While the second-largest crypto asset remains in the red for the week and month, positive momentum is gradually building as the broader market recovers.

Ethereum’s recent underperformance was partly driven by cooling demand for exchange-traded funds tracking the asset. Amid price volatility, Ethereum ETFs recorded approximately $311.8 million in outflows in recent sessions, marking one of the largest since their debut.

A single-day exit of $429 million added further downward pressure, extending the asset’s slide. Issuers, including BlackRock, Fidelity, and Grayscale, posted the most outflows during the stretch, while the rest of the funds recorded no activity.

This mirrored the broader underperformance across the crypto ETF sector, with Bitcoin ETFs posting even stronger outflows of $1.23 billion. The figure marked the second-largest weekly outflow recorded by the funds, fueled by growing pressure amid geopolitical tensions and overall market weakness. 

With market sentiment now improving, Ethereum (ETH) appears poised to continue its uptick.

Ethereum price rebounds despite ETF outflows
ETH’s daily chart shows a recent bounce after a rough few weeks, rebounding off the $3,800–$3,850 support zone and pushing back above the key psychological level of $4,000. The price has attempted to break a short-term descending trendline, suggesting early signs of a potential trend reversal. 

Currently, Ethereum is trading just below the 30-day exponential moving average (EMA), which is acting as immediate resistance around $4,165. A confirmed breakout above both the trendline and the EMA would strengthen the case for further upside toward $4,300 and $4,500.

Ethereum price chart : Source: crypto.news
The MACD remains in bearish territory, but the histogram shows declining negative momentum, hinting at a potential shift in trend if follow-through buying continues.

If Ethereum price holds above $4,000 and momentum continues to build, it could shift sentiment around ETF products. Renewed confidence may lead to fresh inflows into Ethereum ETFs, supporting further price gains in the short term. With technicals showing early signs of recovery and broader market sentiment improving, ETH may be setting up for a stronger move higher.
2025-10-20 12:47 1mo ago
2025-10-20 08:27 1mo ago
Solo Bitcoin Miner Hits the Jackpot Wins $347,000 Block Reward cryptonews
BTC
A solo Bitcoin miner just hit the ultimate crypto jackpot, earning $347,000 from a single block. Against 1-in-7-million odds, the solo miner managed to beat the giants of the industry and take home the full Bitcoin reward. 

The win comes as Bitcoin surges past $111,000, up over 3% in the last 24 hours, with a market cap of $2.21 trillion.

According to on-chain data, a solo Bitcoin miner struck gold this week by successfully solving block 919,923 on Monday around 10:30 UTC, earning 3.1 BTC worth about $347,000. 

The block included 182 transactions, adding a small bonus of 0.001 BTC in fees. The mining was done through Solo CKPool, a platform that allows individuals to mine Bitcoin without operating their own node.

This rare success story once again shows that Bitcoin’s decentralized proof-of-work system still gives small miners a fair shot at winning big.

Beating a 1-in-7-Million ChanceData shows the miner’s hardware produced around 200 terahashes per second (TH/s) similar to a modern Antminer S21, which accounts for just 0.00002% of Bitcoin’s total network hashrate.

With the global hashrate now above 600 exahashes per second, the odds of a solo miner discovering a block are about 1 in 7 million. Most individuals rely on small rigs, while large pools like F2Pool and AntPool dominate the network’s computing power.

It’s a rare event, only about eight solo mining successes have been recorded so far in 2025, highlighting how competitive and random Bitcoin’s proof-of-work system truly is.

The miner’s success comes amid strong bullish sentiment in the Bitcoin market. As of today, BTC trades around $111,000, climbing 4% in the last 24 hours.​

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-10-20 12:47 1mo ago
2025-10-20 08:28 1mo ago
ETHZilla (ETHZ) Stock: Reverse Split Takes Effect for Ethereum Treasury Company cryptonews
ETH
TLDR

Table of Contents

TLDRPutting Ethereum to WorkMarket Reaction and Risk FactorsGet 3 Free Stock Ebooks

ETHZilla Corp (NASDAQ: ETHZ) completed a 1-for-10 reverse stock split on October 20, 2025, raising its share price to around $16.80 to attract institutional investors.
The company holds approximately 102,000 ETH worth over $400 million plus $215 million in cash and stablecoins in its treasury.
Billionaire Peter Thiel’s 7.5% stake disclosure in August triggered a 207% single-day stock surge, though shares have dropped 15% in the past week.
ETHZilla deployed $100 million into Ether.fi staking and $47 million into Puffer Finance while launching a $250 million stock buyback program.
The stock remains up over 90% year-to-date despite recent volatility, with analysts projecting potential ETH price targets of $7,700 by 2026.

ETHZilla Corporation’s transformation from forgotten biotech to crypto powerhouse hit another milestone on October 20, 2025. The company’s 1-for-10 reverse stock split officially took effect, consolidating roughly 160 million shares down to 16 million.

ETHZilla Corporation (ETHZ)
Shares now trade around $16.80 on a post-split basis. That’s down about 15% from the previous week’s levels.

The reverse split wasn’t driven by compliance issues. ETHZilla designed the move to court institutional investors who typically avoid stocks trading below $10.

“As part of ETHZilla’s effort to expand engagement with institutional investors, the reverse split is designed to provide these investors access to collateral and margin availability associated with stock prices greater than $10.00,” the company stated. Many large mutual funds maintain minimum price thresholds regardless of market cap.

The Palm Beach-based company has built an impressive crypto war chest. It holds approximately 102,000 ETH in its treasury, worth over $400 million at current prices.

That makes ETHZilla one of the top six corporate Ethereum holders globally. The company also maintains around $215 million in cash and stablecoins ready for deployment.

ETHZilla’s journey started with a July rebrand from 180 Life Sciences. The biotech firm made a hard pivot to become an Ethereum-focused investment vehicle.

The strategy caught fire in August when billionaire Peter Thiel disclosed a 7.5% stake. Shares rocketed 207% in a single trading session as news of Thiel’s backing spread.

Putting Ethereum to Work
The company isn’t just holding crypto. It’s actively deploying assets into DeFi protocols to generate yield.

ETHZilla committed $100 million of its Ethereum into Ether.fi, a liquid staking protocol. This allows the company to earn staking rewards while maintaining flexibility through tradeable tokens.

The firm then allocated another $47 million into Puffer Finance. This protocol uses “restaking” to compound returns beyond baseline staking yields.

“Beyond baseline staking rewards, Puffer takes advantage of compounding and selling strategies to maximize returns,” explained Amir Forouzani, a Puffer contributor. The goal is boosting annual yields into high single or double digits.

ETHZilla secured a $350 million convertible debenture in September. That cash injection bolstered its balance sheet for future moves.

The company also launched a $250 million share buyback program. To fund repurchases without selling crypto, ETHZilla borrowed $80 million from Cumberland/DRW using part of its Ether holdings as collateral.

This allowed them to buy back about 2.2 million pre-split shares at around $2.50 each. Management calculated the stock was undervalued, with net asset value around $3.99 per share based on total assets.

Executive Chair McAndrew Rudisill said the buyback “underscores our commitment to maximizing value for shareholders.” The company also added Jason New, Vice Chairman of Investment Banking at Lazard, to its board this month.

Market Reaction and Risk Factors
The reverse split announcement initially spooked some investors. Shares fell over 5% the following trading day.

However, management emphasized this wasn’t a desperation move. The split doesn’t change proportional ownership or underlying company value.

Despite the recent pullback, ETHZilla stock remains up over 90% year-to-date. That vastly outperforms the S&P 500’s roughly 13% gain in the same period.

The volatility has been extreme throughout. After peaking in mid-August, the stock fell over 84% from its high by early October.

Technical analysts flagged the stock as “very high risk.” Daily trading ranges have frequently swung 8-10% or more.

ETHZilla itself acknowledged the correlation risk. “ETHZilla’s stock price may be highly correlated to the price of the digital assets that it holds,” the company warned in an SEC filing.

That’s a double-edged sword. If Ethereum soars, ETHZilla’s assets could appreciate dramatically.

If crypto crashes, the company’s valuation could deteriorate just as fast. There’s also execution risk around DeFi protocols and potential smart contract vulnerabilities.

Some analysts see upside potential. Wall Street’s interest in Ethereum is growing, with major firms pursuing Ethereum ETF approvals.

Analyst Rhys Northwood projects ETH could reach $7,700 by 2026 as institutional adoption accelerates. That would roughly double Ethereum’s current price and dramatically boost ETHZilla’s asset values.

“Thiel’s 7.5% ETHZilla stake signals a broader shift to Ethereum as a yield-generating asset,” noted research firm AIvest. Public companies now hold over 1.74 million ETH valued at $6.5 billion on their balance sheets.

Others remain cautious. “We’re in uncharted territory – it’s essentially a crypto ETF plus an active DeFi hedge fund rolled into one stock,” said one crypto investment strategist.

The company has limited operating history in this new domain. Its fate hinges almost entirely on Ethereum’s performance and DeFi execution.

Regulatory changes remain a wildcard. U.S. regulators have been favorable so far, classifying Ether as a non-security utility token in 2025.

However, global rules for corporate crypto treasury operations are still evolving. Any regulatory shifts could impact ETHZilla’s strategy.

The stock has dropped in seven of the last ten trading days. Momentum indicators recently hit oversold levels, which sometimes precede bounces but can also signal extended declines.

ETHZilla reports Q3 2025 earnings on October 23. Investors will be watching for details on revenue from DeFi deployments and future acquisition plans.
2025-10-20 12:47 1mo ago
2025-10-20 08:30 1mo ago
Dogecoin 3rd Cycle Explosion: Analyst Revels The Only Difference From Last Two Cycles cryptonews
DOGE
Dogecoin is once again in the spotlight after analyst ETHERNASYONAL shared a new post on X about the coin’s next move. In his post, he shows that Dogecoin is now in its 3rd market cycle, and the pattern looks a lot like what happened before the last two big rallies. He says Dogecoin is moving in the same rhythm as before, showing signs that it could be getting ready for another substantial rise. But this time, he points out one big difference, the timing. 

According to him, history doesn’t really repeat itself; it just continues in rhythm. The setup looks the same, but the next move might happen at a different pace. Analysts are now watching closely to see if this familiar pattern will lead to another big explosion in price. His chart shows Dogecoin slowly building strength again, much like it did before its earlier breakouts.

ETHERNASYONAL Spots Familiar Pattern In Dogecoin’s 3rd Cycle
In his post on X, ETHERNASYONAL shared a chart that shows Dogecoin entering what he calls its 3rd cycle. The chart compares the current market setup with the 1st and 2nd cycles, both of which ended in upward moves. The same kind of shape is forming again, a slow and steady climb that could lead to another sharp breakout.

Source: X
He explains that Dogecoin’s behavior does not copy the past in exact detail. Instead, it keeps the same rhythm. Each time the pattern builds, the market seems to prepare for a new run. The chart shows how in both past cycles, Dogecoin spent months moving in a tight range before a big surge started. The same look is now forming again.

ETHERNASYONAL says this shows that Dogecoin is following a cyclical path. The rhythm stays the same, even if each cycle has its own pace

The Only Difference Now Is Timing, Says Analyst
While the setup looks almost the same as before, ETHERNASYONAL says that this time, the timing will be different. In his words, “History doesn’t repeat itself. It just continues its rhythm. This time, the difference will be timing.” He explains that the market may not move as fast as it did in past cycles, but it is still preparing for something big.

His post on X says Dogecoin is preparing the 3rd cycle, meaning Dogecoin’s next phase is forming step by step. Traders should watch for when the market starts to show stronger signs of a breakout. According to him, the main thing to focus on now is not the chart’s shape, which already looks bullish — but how long this setup will take to play out.

ETHERNASYONAL believes that timing is now the key factor that will decide how big Dogecoin’s next rally becomes. The same rhythm is there, and the structure remains strong. What changes now is when the move will happen.

DOGE continues to trade sideways | Source: DOGEUSDT on Tradingview.com
Featured image created with Dall.E, chart from Tradingview.com
2025-10-20 12:47 1mo ago
2025-10-20 08:30 1mo ago
Synthetix Price Prediction: SNX Up 20% in 24H, Is A Push Above $2 Coming Today? cryptonews
SNX
The price of SNX has gone up by 20% in the past 24 hours as the project's $1 million trading competition kicked off today. Alongside the upcoming launch of its perpetual futures trading platform, the start of this event favors a bullish Synthetix price prediction.
2025-10-20 12:47 1mo ago
2025-10-20 08:39 1mo ago
What to expect from Federal Reserve's Bitcoin and crypto payments conference? cryptonews
BTC
The Federal Reserve will host a conference on Oct. 21, covering topics like stablecoins, AI, crypto payments, and many more. Here’s what to expect from the talks and who will be there.

Summary

The Federal Reserve’s Payments Innovation Conference on Oct. 21 will mark one of the first official dialogues between U.S. central bank officials and crypto industry leaders.
The conference will focus on bridging traditional finance with digital assets, stablecoins, AI in payments, and tokenized products. The Fed invites top figures from firms like Chainlink, Circle, Coinbase, and BlackRock to take part.

The Fed is set to host a conference on Oct. 21 that is expected to make waves in the U.S crypto space. Dubbed the “Payments Innovation Conference,” the event will bring together several leading experts from the decentralized finance and crypto sector to engage with the central bank on a number of topics.

The conference itself is meant to encourage open dialogue between Fed officials and crypto industry leaders on the ever-changing financial landscape. It will also give central bank leaders an opportunity to widen their perspective on the many different emerging types of payment options provided by the crypto space.

“The Federal Reserve welcomes the opportunity to consider a broad range of perspectives on how to further innovate and improve the payment system,” said the agency in a statement.

The event marks one of the first times the Federal Reserve is explicitly convening a conference centered around crypto and digital assets. The conference is set to take place in Washington D.C, with opening remarks delivered by Federal Reserve Governor Christopher J. Waller.

According to the Fed’s official website, the conference will feature a series of round-table discussions with panelists from both the banking and crypto industries. The event will be livestreamed on the Fed’s YouTube channel and on the official site federalreserve.gov.

For the crypto market, this kind of event could boost investor confidence in the sector, considering how closely linked the crypto market performance is with Fed decisions. Statements made or signals given at the conference could shift expectations around regulation, institutional participation, or infrastructure rollout.

The Federal Reserve will host a conference on Oct. 21 centered around crypto payments, AI, and stablecoins | Source: Federal Reserve
What’s on the Federal Reserve’s agenda for crypto?
The first discussion will commence at 9.20 AM local time, with the theme of “Bridging traditional finance with the digital asset ecosystem.”

The talk will be moderated by Chief Legal Officer at Jito Labs, Rebecca Rettig, and feature a number of crypto figures, including Chainlink CEO and Co-Founder Sergey Nazarov, Lead Bank CEO Jackie Reses, Fireblocks CEO Michael Shaulov, and Global Head of Treasury Services & Depositary Receipts at BNY, Jennifer Barker.

The second panel discussion will focus on stablecoins, specifically their use cases and business models. With Multicoin Capital’s Co-Founder Kyle Samani as moderator, the roundtable will feature Circle’s (USDC) President Heath Tarbert, Dolar App CEO Fernando Terres, Fifth Third Bank CEO Tim Spence, and Paxos Co-Founder and CEO Charles Cascarilla.

The third roundtable will center around the role of AI in payments and is moderated by Matt Marcus from Modern Treasury. A number of major leaders from crypto and decentralized finance will take part in the roundtable, including Ark Invest CEO Cathie Wood, Coinbase CFO Alesia Haas, Head of AI at Stripe Emily Sands, and Managing Director, Web3 and Digital Assets at Google Cloud James Tromans.

For the last roundtable discussion, the panelists will talk about Tokenized Products. Moderated by Co-Head of Ventures at Brevan Howard, Colleen Sullivan, the final debate at the conference will feature Franklin Templeton CEO Jenny Johnson, Founder and CEO of DRW Trading Group, Don Wilson, BlackRock COO, Rob Goldstein, and JPM Kinexys Co-Head, Kara Kennedy.

The conference will end with closing remarks from Governor Christopher J. Waller.
2025-10-20 12:47 1mo ago
2025-10-20 08:46 1mo ago
Tron Price Prediction 2025, 2026 – 2030: Can Tron Reach $1 in 2025? cryptonews
TRX
Story HighlightsThe live price of the Tron coin is  $ 0.32250044Tron crypto could reach a maximum of $0.73 in 2025.TRX coin price could go as high as $3.55 by 2030.Tron has been scaling steadily, powered by its decentralized community governance and diverse offerings such as SunSwap, Tron Wallet, JustStable, and Just DAO. Known for speed, scalability, and low fees, it has built a solid position in the blockchain world. In a notable event, the Tron founder, Justin Sun, has announced the transaction fee cut by 60%.

With the overall market taking an uncertain influence, questions like “Is TRX a good investment?” are rising in the crowd. With Coinpedia’s technical analysis, recent updates, developments, and various price prediction methods, we can ride the TRX price action from 2025 up to 2030.

TRON Price TodayCryptocurrencyTRONTokenTRXPrice$0.3225 1.31% Market Cap$ 30,529,928,911.7924h Volume$ 652,374,884.9961Circulating Supply94,666,315,739.3223Total Supply94,666,323,704.5507All-Time High$ 0.4407 on 03 December 2024All-Time Low$ 0.0011 on 15 September 2017TRX Price ChartTRON (TRX) trades around $0.311 after a recent decline.​​Key support is at $0.314 and $0.307, resistance stands at $0.333 and $0.353.​​Price sits below its 50-day SMA ($0.334) and slightly under the 200-day SMA ($0.314), signaling short-term bearishness.​​RSI reads 34, showing sellers dominate but not yet oversold.​​MACD appears flat, indicating sideways momentum.​​Short-term outlook is neutral to bearish; volatility remains compressed.Tron Short-Term Price PredictionTron Price Prediction for October 2025Tron is trading near $0.311 after falling from the $0.355 resistance. The RSI indicates oversold conditions, suggesting a potential cooling phase. Key support lies at $0.30, which has held well recently. If bulls regain momentum and breach $0.355, the next target could be $0.38. For September 2025, TRX may trade between $0.30, $0.345, and $0.38, depending on broader market sentiment and breakout strength above key resistance levels.

MonthPotential LowPotential AveragePotential HighOctober0.30.3450.38TRON Price Prediction 2025According to CryptoQuant, TRON has now processed over 11.1 billion lifetime transactions, showing how far the network has come. Between early May and mid-August alone, about 860 million transactions were recorded, proving consistent demand within its ecosystem. Beyond these figures, large investor activity points toward increasing institutional interest, which supports confidence in TRON’s long-term future.

On an optimistic note, investors can find the TRX coin price sustaining above the psychological barrier of $0.70 and creating another swing high at $0.73. In case of a bearish correction, the TRX prices might slide down to $0.39, making an average price of $0.56.

Year Potential LowPotential AveragePotential High20250.390.560.73Also, read our Ethereum Price Prediction 2025, 2026 – 2030!

TRON Mid-Term Price TargetsYearPotential Low ($)Potential Average ($)Potential High ($)20260.600.851.1020270.771.131.49TRX Price Prediction 2026By 2026, the TRX coin price is expected to hit a high of $1.10, surpassing the next crucial psychological level of $1.00. In case of an economic slowdown, the TRX price is expected to make a low of $0.60, with an average of $0.85.

TRON Coin Price Projection 2027With a potential recovery in 2027, the TRX price is expected to continue the bull run and retest the high of $1.49. On the flip side, the TRX crypto can bottom out at $0.77, with an average of $1.13.

TRX Long-Term Price PredictionYearPotential Low ($)Potential Average ($)Potential High ($)20280.941.502.0720291.352.012.6820301.822.693.55TRON Crypto Price Forecast 2028With continued bullish momentum in 2028, the TRX price can form a range between $0.94 and $2.07, with an average price of $1.50.

TRON Token Price Action 2029The TRX price is expected to surpass the psychological barrier of $2.50. Creating a new swing high at $0.2.68, the TRX crypto might form a low at $1.35, with an average of $2.01.

TRON (TRX) Price Prediction 2030TRX coin price is expected to create a new all-time high of $3.55 in 2030. With a potential low of $1.82, the crypto will have an average price of $2.69.

Tron Price Prediction 2031, 2032, 2033, 2040, 2050YearPotential Low ($)Potential Average ($)Potential High ($)20312.083.344.6120322.734.416.0920333.525.677.83204014.0820.8727.67205084.66127.87171.09Market AnalysisFirm Name202520262030Changelly$0.272$0.355$1.71Coincodex$0.275$0.265$0.490Binance$0.272$0.285$0.347CoinPedia’s TRX Price PredictionBased on Coinpedia’s TRON price forecast, the anticipated price of the TRON cryptocurrency could potentially peak at $0.73 this year.

However, should bearish trends prevail, the value of TRON might plummet to a low of $0.39. Consequently, the expected average price stands at approximately $0.56.

We expect the TRX coin price to reach a high of $0.73 in 2025.

Year Potential LowPotential AveragePotential High20250.390.560.73Reality Check: Obstacles on the Road to $1While the future is bright, TRX will face challenges in reaching $1. Key among the risks:

Competition from other blockchains like Ethereum, Cardano, and Polkadot, which have large developer communities and resource advantages. Emerging layer-1s are also racing to scale.Regulatory hurdles remain if governments restrict crypto usage or impose new rules around decentralized applications. Increased scrutiny could dampen growth.Market volatility is inevitable, as seen from past crypto winters. One uncertain macro event may lead to sudden price drops, impairing TRX momentum in the short term.Also, read our Solana Price Prediction 2025, 2026 – 2030!

FAQsIs Tron a good investment?

Yes, Tron coin is a profitable investment if considered for the long term.

How High can TRX go by the end of 2030?

However, with increased adoption and rising demands, the Tron price can reach $3.55 by 2030.

Is Tron Blockchain better than Ethereum Blockchain?

The Ethereum ecosystem is currently facing a serious problem of gas fees. Therefore, addressing the issue, TRON Blockchain claims to lower transaction fees by allowing gas-free transactions using USDT.

Can TRX reach $1 in 2025?

According to CoinPedia’s TRX price prediction. The digital asset could close its trade with a maximum price tag of $0.73 by 2025. 

How to buy TRON?

TRON’s TRX is available for trades across prominent cryptocurrency exchange platforms such as Binance, Coinbase, Zebpay, and Kraken.

How much would the price of Tron be in 2040?

As per our latest TRX price analysis, Tron could reach a maximum price of $27.67.

How much will the TRX coin price be in 2050?

By 2050, a single Tron price could go as high as $171.09.

Disclaimer and Risk WarningThe price predictions in this article are based on the author's personal analysis and opinions. CoinPedia does not endorse or guarantee these views. Investors should conduct independent research before making any financial decisions.
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Sandstorm Gold Royalties Closes Arrangement with Royal Gold stocknewsapi
SAND
, /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement") with Royal Gold, Inc. ("Royal Gold"), whereby Royal Gold indirectly acquired all of the issued and outstanding common shares of Sandstorm (the "Sandstorm Shares").

Pursuant to the Arrangement, Sandstorm shareholders were entitled to receive 0.0625 of a share of common stock of Royal Gold for each Sandstorm Share held (the "Consideration").

The Sandstorm Shares are expected to be delisted from the Toronto Stock Exchange and the New York Stock Exchange within two to three business days following the date hereof. Sandstorm will also apply to the Canadian securities regulators for the Company to cease to be a reporting issuer in the applicable jurisdictions, and will deregister the Sandstorm Shares under the U.S. Securities Exchange Act of 1934, as amended.

Further details of the Arrangement are set out in Sandstorm's Management Information Circular dated September 8, 2025 (the "Circular") and related continuous disclosure documents, which are available under the Company's profile on SEDAR+ at www.sedarplus.ca, and on Edgar Next at www.sec.gov.

Shareholders are reminded to review the Circular in respect of the procedure for receiving the Consideration for their Sandstorm Shares. Registered shareholders (Sandstorm Shares held in physical form or a direct registration system ("DRS") advice) must complete, sign and return the letter of transmittal, along with their share certificate(s) or DRS advice(s), to Computershare Investor Services Inc., the depositary for the Arrangement. Non-registered shareholders (Sandstorm Shares held with a broker, bank or other intermediary) should contact their intermediaries for instructions and assistance in receiving the Consideration for such Sandstorm Shares.

While the Canada Post strike is ongoing, registered shareholders who wish to deposit their letters of transmittal, share certificates and other required documentation, as applicable, should use courier services or hand deliver such documentation to the depositary, Computershare Investor Services Inc., at 320 Bay Street, 14th Floor, Toronto, Ontario M5H 4A6.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This press release contains "forward-looking statements", within the meaning of the U.S. Securities Act of 1933, the U.S. Securities Exchange Act of 1934, the Private Securities Litigation Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation, concerning the business, operations and financial performance and condition of Sandstorm Gold Royalties. Forward-looking statements include, but are not limited to, the delisting of the Sandstorm Shares from the Toronto Stock Exchange and New York Stock Exchange following completion of the Arrangement, the filing of the application to cease to be a reporting issuer in the applicable jurisdiction following completion of the Arrangement, and the de-registration of Sandstorm Shares under the U.S. Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking terminology such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe", "continue", "plans", or similar terminology.

Forward-looking statements are made based upon certain assumptions and other important factors that, if untrue, could cause the actual results, performances or achievements of Sandstorm Gold Royalties to be materially different from future results, performances or achievements expressed or implied by such statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which Sandstorm Gold Royalties will operate in the future, including the receipt of all required approvals, the price of gold and copper and anticipated costs. Certain important factors that could cause actual results, performances or achievements to differ materially from those in the forward-looking statements include, amongst others, failure to receive necessary approvals, changes in business plans and strategies, market conditions, share price, best use of available cash, gold and other commodity price volatility, discrepancies between actual and estimated production, mineral reserves and resources and metallurgical recoveries, mining operational and development risks relating to the parties which produce the gold or other commodity the Company will purchase, regulatory restrictions, activities by governmental authorities (including changes in taxation), currency fluctuations, the global economic climate, dilution, share price volatility and competition.

Forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: the impact of general business and economic conditions, the absence of control over mining operations from which the Company will purchase gold, other commodities or receive royalties from, and risks related to those mining operations, including risks related to international operations, government and environmental regulation, actual results of current exploration activities, conclusions of economic evaluations and changes in project parameters as plans continue to be refined, risks in the marketability of minerals, fluctuations in the price of gold and other commodities, fluctuation in foreign exchange rates and interest rates, stock market volatility, as well as those factors discussed in the section entitled "Risks to Sandstorm" in the Company's annual report for the financial year ended December 31, 2024 and the section entitled "Risk Factors" contained in the Circular and the Company's annual information form dated March 31, 2025 available at www.sedarplus.com. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not undertake to update any forward-looking statements that are contained or incorporated by reference, except in accordance with applicable securities laws.

SOURCE Sandstorm Gold Ltd.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Consolidated Lithium Metals to Host Live Webinar to Discuss Corporate Update stocknewsapi
JORFF
TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36) (“CLM” or the “Company”) is pleased to announce that it will be hosting a corporate update presentation with analysts and investors via live webinar on Wednesday, October 22, 2025, at 4:30 p.m. (Toronto time). Participants can register to attend at the following web address:
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
McFarlane Lake Announces Sale of High Lake and West Hawk Lake Properties for $9.25 Million stocknewsapi
MLMLF
October 20, 2025 7:30 AM EDT | Source: McFarlane Lake Mining Limited
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - McFarlane Lake Mining Limited (CSE: MLM) (OTCQB: MLMLF) ("McFarlane" or the "Company") is pleased to announce the signing of a definitive asset purchase agreement (the "Agreement") with Total Metals Corp. ("Total Metals") for the sale of the Company's High Lake and West Hawk Lake properties located in close proximity east and west of the Ontario-Manitoba border.

Under the terms of the Agreement, the Company will receive total consideration of $9.25 million, comprised of:

$7.25 million in cash, payable on closing; and 3,333,333 common shares of Total Metals, issued at a deemed price equal to $0.60 per share, and issuable on closing. Completion of the transaction is conditional on Total Metals raising at least $10 million in gross proceeds from a concurrent financing and other customary closing conditions, including required regulatory and third-party approvals, with the transaction expected to close on or before October 31, 2025.

About McFarlane Lake Mining Limited

McFarlane Lake Mining Limited ("McFarlane" or the "Company") is a Canadian gold exploration company focused on advancing its flagship Juby Gold Project, located near Gowganda, Ontario, within the established Abitibi Greenstone Belt. The Juby Project hosts a current (effective September 29, 2025) NI 43-101 compliant Mineral Resource Estimate (MRE) of 1.01 million ounces of gold in the Indicated category at an average grade of 0.98 g/t gold (31.74 million tonnes) and an additional 3.17 million ounces of gold in the Inferred category at an average grade of 0.89 g/t gold (109.48 million tonnes). The estimate was calculated using a long-term gold price of US$2,500 per ounce, applying cut-off grades of 0.25 g/t gold for open pit and 1.85 g/t gold for underground resources.

A sensitivity analysis completed at a higher gold price of US$3,750 per ounce resulted in an Indicated Mineral Resource of 1.20 million ounces grading 0.94 g/t gold (39.51 million tonnes) and an Inferred Mineral Resource of 4.23 million ounces grading 0.85 g/t gold (154.50 million tonnes) applying cut-off grades of 0.25 g/t gold for open pit and 1.15 g/t gold for underground resources.

The independent MRE was prepared by BBA E&C Inc. in accordance with National Instrument 43-101 — Standards of Disclosure for Mineral Projects. The full technical report supporting the resource estimate will be filed on SEDAR+ within 45 days of the Company's public announcement of the MRE.

McFarlane is actively planning an exploration drilling program and additional technical studies at the Juby Project to further evaluate and advance this large-scale gold system.

In addition to Juby, McFarlane holds a portfolio of 100%-owned gold assets across Ontario and Manitoba, including the past-producing McMillan Gold Mine and Mongowin properties located approximately 70 kilometres west of Sudbury, the High Lake and West Hawk Lake properties situated along the Ontario-Manitoba border, and the Michaud/Munro properties located 115 kilometres east of Timmins. McFarlane Lake Mining Limited is a reporting issuer in Ontario, British Columbia, and Alberta.

Readers are cautioned to refer to the "Cautionary Statement on Mineral Resources," and all other disclaimers included in this news release for important information regarding the limitations and verification status of the data presented above and elsewhere herein.

To learn more, visit: https://mcfarlanelakemining.com/.

Additional information on McFarlane can be found by reviewing its profile on SEDAR+ at www.sedarplus.ca.

Qualified Person

The scientific and technical information disclosed in this news release was reviewed and approved by Wesley Whymark, P. Geo., Consulting Geologist for the company, and a Qualified Person as defined under National Instrument 43-101. Technical information was also reviewed by Mark Trevisiol P.Eng., an officer of McFarlane and a Qualified Person under National Instrument 43-101.

Advisors

Wildeboer Dellelce LLP is acting as legal counsel for McFarlane.

Cautionary Note Regarding Forward-Looking Information:

This news release contains "forward-looking information" or "forward-looking statements" within the meaning of Canadian securities legislation. All statements included herein, other than statements of historical fact, including, without limitation, statements relating to the timeline for the completion of the transaction, the ability of McFarlane to satisfy or waive closing conditions under the Agreement, including receipt of required regulatory and third-party approvals. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", "is expected", "anticipates" or "does not anticipate", "plans", "believes" or "intends", or variations of such words and phrases, or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements.

Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of McFarlane to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption "Risk Factors" in the Company's Annual Information Form dated as of November 27, 2024, which is available for view on SEDAR+ at www.sedarplus.ca. Forward-looking statements contained herein are made as of the date of this press release and McFarlane disclaims, other than as required by law, any obligation to update any forward-looking statements whether as a result of new information, results, future events, circumstances, or if management's estimates or opinions should change, or otherwise.

There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.

Cautionary Statement on Mineral Resources

This news release uses the terms indicated and inferred mineral resources as a relative measure of the level of confidence in the resource estimate. Readers are cautioned that mineral resources are not mineral reserves and that the economic viability of resources that are not mineral reserves has not been demonstrated. The mineral resource estimates disclosed in this news release may be materially affected by geology, environmental, permitting, legal, title, socio-political, marketing or other relevant issues. It cannot be assumed that all or any part of an inferred mineral resource will ever be upgraded to an indicated or measured mineral resource category, however, it is reasonably expected that the majority of Inferred Mineral Resources could be upgraded to Indicated Mineral Resources with continued exploration. The mineral resource estimate is classified in accordance with the Canadian Institute of Mining, Metallurgy and Petroleum's "CIM Definition Standards on Mineral Resources and Mineral Reserves" incorporated by reference into NI 43-101. Under NI 43-101, estimates of inferred mineral resources may not form the basis of feasibility or pre-feasibility studies or economic studies except for preliminary economic assessments. Readers are cautioned not to assume that further work on the stated resources will lead to mineral reserves that can be mined economically.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271024
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Standard Uranium Confirms High-Grade Uranium Mineralization up to 8.10% U3O8 at Surface on the Corvo Project stocknewsapi
STTDF
Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab samples.
October 20, 2025 7:30 AM EDT | Source: Standard Uranium Ltd.
Vancouver, British Columbia--(Newsfile Corp. - October 20, 2025) - Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company") is pleased to announce final assay results from its 2025 exploration programs the Corvo Uranium Project ("Corvo", or the "Project"), currently under a three-year earn-in option agreement with Aventis Energy Inc. ("Aventis") (CSE: AVE).

From July 4 to July 16, 2025, the Company completed a detailed mapping and sampling program across historical uranium showings and zones of interest on the Project. Assay results confirm uranium mineralization across the Project, including high-grade* surface mineralization at the Manhattan Showing.

Highlights:

High-Grade Uranium at Surface: Verification of surficial uranium mineralization across the Project, including the historical Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab samples.

Discovery of New Radioactive Showings: Scintillometer prospecting uncovered previously undocumented radioactive occurrences across the Project in favorable rock types for uranium and Rare Earth Element ("REE") mineralization.

Ongoing Exploration: An extensive ground gravity survey is scheduled for December 2025, designed to identify density anomalies potentially representing hydrothermal alteration systems coincident with newly refined EM conductor trends across the Project. A diamond drill program is being planned for Q1 2026 to begin testing targets developed and ranked through the successful programs executed in 2025.

"Our geochemical assays returning the highest uranium grades ever reported on the Project increases our confidence and excitement, as we were able to repeat historic results and identify new areas of mineralization at surface," said Sean Hillacre, President & VP Exploration of Standard Uranium. "We will continue to bolster our targeting strategy through the December ground gravity program leading into the first drill program on the Project in more than 40 years."

Figure 1. Regional map of the Corvo Project. The Project is located 60 km due east of Cameco's McArthur River mine and 45 km northeast of Atha Energy's Gemini Mineralized Zone ("GMZ").

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10633/270985_03afcce444773bc1_001full.jpg

2025 Prospecting Program - Geochemical Assay Results

Beginning July 4 and concluding July 16, 2025, the Standard Uranium technical team completed a detailed mapping, prospecting, and sampling program to ground-truth historical uranium showings at surface on the Project. Prospecting confirmed several uraniferous outcrops and boulders across the Project, including at the Manhattan showing (0.72% to 8.10% U3O8; Figure 2).

A total of 30 outcrop and boulder grab samples were submitted to Saskatchewan Research Council Geoanalytical Laboratories in Saskatoon, SK, an ISO/IEC 17025:2017 and Standards Council of Canada certified analytical laboratory, for whole-rock, uranium, and REE geochemical analysis. Uranium and Total Rare Earth Element Oxides including Yttrium oxide (TREO*) results from 28 radioactive samples are summarized below in Table 1. Oxide TREO* values in Table 1 refer to total amounts of the REE oxides in the lanthanide series plus the chemically similar element Yttrium (Y2O3). Parts per million ("ppm") values are converted to oxide wt.% values through the applicable conversion factor relating to each REE oxide and then summed3.

Table 1. Corvo 2025 Prospecting Uranium and TREO* Geochemical Assays

SampleEastingNorthingTypeLithologyUranium
(total, ppm)U3O8
(wt.%)TREO*
(wt.%)Manhattan Showing:2140105610996408003OutcropParagneiss65,7008.1000.1902449595611026408006OutcropParagneiss51,1005.1400.1442140115610996408003OutcropParagneiss32,4004.2300.1242449605611026408006OutcropParagneiss5,9600.7180.041

2449625617076406667BoulderPegmatite2,1600.2600.0542449755620856408020OutcropOrthogneiss8450.0950.0362449645609196405920BoulderPegmatite5750.0590.0832449735617906406254OutcropOrthogneiss2870.0340.0582449545634826407023OutcropLithological Contact3630.0330.1392449565637226407404BoulderPegmatite2910.0290.0232449515623486405779OutcropPegmatite2610.0220.0132449695582456405053BoulderPegmatite1430.0220.0892449715588166406058BoulderOrthogneiss2580.0190.0222449665608076406127OutcropPegmatite68.60.0160.0722449615611086408008OutcropParagneiss1500.0160.0552449655608076406127OutcropPegmatite2040.0130.0542449705590106405565OutcropPegmatite1190.0120.0172449585612886404091BoulderPegmatite1100.0120.0482449635617866406272OutcropPegmatite43.40.0090.0102449765592946407164OutcropPegmatite92.80.0080.0232449675607836406159OutcropPegmatite 22.80.0030.1142449575641506407779BoulderPegmatite40.40.0030.0082449745603826407282OutcropParagneiss2.810.0020.0232449725617866406276OutcropPegmatite23.90.0020.0092449525617446405987OutcropPegmatite150<0.0010.1272449685610226406015BoulderPegmatite101<0.0010.1212449555635346407318OutcropPegmatite19.7<0.0010.2932449535617036405969OutcropPegmatite15.3<0.0010.024

Figure 2. Manhattan Showing high-grade samples (Left) Hand sample 244959 - 5.14 wt.% U3O8 (Right) Hand sample 214010 - 8.10 wt.% U3O8. Scale bars units are metric (cm / mm).

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10633/270985_03afcce444773bc1_002full.jpg

Corvo Exploration

Supplementary geophysical surveys across the Project have been designed to further refine drill targets for an inaugural drill program in 2026. The Company will complete a high-resolution ground gravity survey across the main conductive trends on the Project, aiming to identify potential hydrothermal alteration halos which could be related to basement-hosted uranium mineralization.

Earlier this year, the Company contracted Axiom Exploration Group Ltd. in partnership with New Resolution Geophysics to carry out a helicopter-borne Xcite time domain electromagnetic and total field magnetic survey over the Corvo Project2. The survey totalled approximately 1,380 line-kms with a traverse line spacing of 100 m and tie-line spacing of 1,000 m. The airborne TDEM survey outlines several kilometers of conductive anomalies and magnetic features in bedrock, effectively enhancing the resolution of more than 29 kilometres of conductive trends on the project.

Ongoing geophysical interpretation and modeling is being completed to integrate historical surveys with newly collected datasets, which will provide high-priority drill targets and significantly derisk the Project prior to modern drilling in 2026.

The Company believes the Project is highly prospective for the discovery of shallow, high-grade basement-hosted uranium mineralization akin to the Rabbit Lake deposit and the recently discovered Gemini Mineralized Zone. Located just outside the current margin of the Athabasca Basin, Corvo boasts shallow drill targets with bedrock under minimal cover of glacial till.

Qualified Person Statement

The scientific and technical information contained in this news release has been reviewed, verified, and approved by Sean Hillacre, P.Geo., President and VP Exploration of the Company and a "qualified person" as defined in NI 43-101 - Standards of Disclosure for Mineral Projects.

Samples collected for analysis were sent to SRC Geoanalytical Laboratories in Saskatoon, Saskatchewan for preparation, processing, and ICP-MS or ICP-OES multi-element analysis using total and partial digestion and boron by fusion. Radioactive samples were tested using the ICP1 uranium multi-element exploration package plus boron. All samples marked as radioactive upon arrival to the lab were also analyzed using the U3O8 assay (reported in wt.%). SRC is an ISO/IEC 17025:2005 and Standards Council of Canada certified analytical laboratory. Blanks, standard reference materials, and repeats were inserted into the sample stream at regular intervals in accordance with Standard Uranium's quality assurance/quality control (QA/QC) protocols. All samples passed internal QA/QC protocols and the results presented in this release are deemed complete, reliable, and repeatable.

REE oxide conversion factors3 were verified using the following formulas:
Convert REE (Rare Earth Element) ppm to REO (Rare Earth Oxide): REO % = (ppm / Atomic Weight of REE) * (Molecular Weight of REO / 10,000).

Element-to-oxide conversion factor: Molecular weight of the oxide / atomic weight of the element. For oxides with more than one metal cation, account for the number of cations in the formula.

Historical data disclosed in this news release relating to sampling results from previous operators are historical in nature. Neither the Company nor a qualified person has yet verified this data and therefore investors should not place undue reliance on such data. The Company's future exploration work may include verification of the data. The Company considers historical results to be relevant as an exploration guide and to assess the mineralization as well as economic potential of exploration projects. Any historical grab samples disclosed are selected samples and may not represent true underlying mineralization.

Natural gamma radiation from rocks reported in this news release was measured in counts per second ("cps") using a handheld RS-125 super-spectrometer and RS-120 super-scintillometer. Readers are cautioned that scintillometer readings are not uniformly or directly related to uranium grades of the rock sample measured and should be treated only as a preliminary indication of the presence of radioactive minerals. The RS-125 and RS-120 units supplied by Radiation Solutions Inc. ("RSI") have been calibrated on specially designed Test Pads by RSI. Standard Uranium maintains an internal QA/QC procedure for calibration and calculation of drift in radioactivity readings through three test pads containing known concentrations of radioactive minerals. Internal test pad radioactivity readings are known and regularly compared to readings measured by the handheld scintillometers for QA/QC purposes.

References
1 SMDI# 2052: https://mineraldeposits.saskatchewan.ca/Home/Viewdetails/2052 & Mineral Assessment Report MAW00047: Eagle Plains Resources Inc., 2011-2012
2 Standard Uranium Provides Exploration Update Highlighting Results of Gravity and TDEM Surveys on Three Eastern Athabasca Uranium Projects, News Release, March 13, 2025. https://standarduranium.ca/news-releases/standard-uranium-provides-exploration-update-tdem-surveys-on-three-eastern-athabasca-uranium/
3 https://www.jcu.edu.au/advanced-analytical-centre/resources/element-to-stoichiometric-oxide-conversion-factors
*The Company considers uranium mineralization with concentrations greater than 1.0 wt% U3O8 to be "high-grade".
**The Company considers radioactivity readings greater than 65,535 counts per second (cps) on a handheld RS-125 Super-Spectrometer to be "off-scale".
***The Company considers radioactivity readings greater than 300 counts per second (cps) on a handheld RS-125 Super-Spectrometer to be "anomalous".

About Standard Uranium (TSXV: STND)

We find the fuel to power a clean energy future

Standard Uranium is a uranium exploration company and emerging project generator poised for discovery in the world's richest uranium district. The Company holds interest in over 235,435 acres (95,277 hectares) in the world-class Athabasca Basin in Saskatchewan, Canada. Since its establishment, Standard Uranium has focused on the identification, acquisition, and exploration of Athabasca-style uranium targets with a view to discovery and future development.

Standard Uranium's Davidson River Project, in the southwest part of the Athabasca Basin, Saskatchewan, comprises ten mineral claims over 30,737 hectares. Davidson River is highly prospective for basement-hosted uranium deposits due to its location along trend from recent high-grade uranium discoveries. However, owing to the large project size with multiple targets, it remains broadly under-tested by drilling. Recent intersections of wide, structurally deformed and strongly altered shear zones provide significant confidence in the exploration model and future success is expected.

Standard Uranium's eastern Athabasca projects comprise over 43,185 hectares of prospective land holdings. The eastern basin projects are highly prospective for unconformity related and/or basement hosted uranium deposits based on historical uranium occurrences, recently identified geophysical anomalies, and location along trend from several high-grade uranium discoveries.

Standard Uranium's Sun Dog project, in the northwest part of the Athabasca Basin, Saskatchewan, is comprised of nine mineral claims over 19,603 hectares. The Sun Dog project is highly prospective for basement and unconformity hosted uranium deposits yet remains largely untested by sufficient drilling despite its location proximal to uranium discoveries in the area.

Cautionary Statement Regarding Forward-Looking Statements

This news release contains "forward-looking statements" or "forward-looking information" (collectively, "forward-looking statements") within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as of the date of this news release. Forward-looking statements include, but are not limited to, statements regarding: the timing and content of upcoming work programs; geological interpretations; timing of the Company's exploration programs; and estimates of market conditions.

Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those expressed or implied by forward-looking statements contained herein. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Certain important factors that could cause actual results, performance or achievements to differ materially from those in the forward-looking statements are highlighted in the "Risks and Uncertainties" in the Company's management discussion and analysis for the fiscal year ended April 30, 2025.

Forward-looking statements are based upon a number of estimates and assumptions that, while considered reasonable by the Company at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies that may cause the Company's actual financial results, performance, or achievements to be materially different from those expressed or implied herein. Some of the material factors or assumptions used to develop forward-looking statements include, without limitation: that the transaction with the Optionee will proceed as planned; the future price of uranium; anticipated costs and the Company's ability to raise additional capital if and when necessary; volatility in the market price of the Company's securities; future sales of the Company's securities; the Company's ability to carry on exploration and development activities; the success of exploration, development and operations activities; the timing and results of drilling programs; the discovery of mineral resources on the Company's mineral properties; the costs of operating and exploration expenditures; the presence of laws and regulations that may impose restrictions on mining; employee relations; relationships with and claims by local communities and indigenous populations; availability of increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development (including the risks of obtaining necessary licenses, permits and approvals from government authorities); uncertainties related to title to mineral properties; assessments by taxation authorities; fluctuations in general macroeconomic conditions.

The forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Any forward-looking statements and the assumptions made with respect thereto are made as of the date of this news release and, accordingly, are subject to change after such date. The Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270985
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Aventis Energy Confirms High-Grade Uranium Mineralization up to 8.10% U₃O₈ at Surface on the Corvo Project stocknewsapi
VBAMF
VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce final assay results from its 2025 exploration program at the Corvo Uranium Project (“Corvo”, or the “Project”), currently under a three-year earn-in option agreement with Standard Uranium Ltd. (“Standard”).

From July 4 to July 16, 2025, the Company completed a detailed mapping and sampling program across historical uranium showings and zones of interest on the Project. Assay results confirm uranium mineralization across the Project, including high-grade* surface mineralization at the Manhattan Showing.

Highlights:

High-Grade Uranium at Surface: Verification of surficial uranium mineralization across the Project, including the historical Manhattan Showing with assay results returning uranium grades ranging from 0.72% to 8.10% U3O8 in outcrop grab samples.Discovery of New Radioactive Showings: Scintillometer prospecting uncovered previously undocumented radioactive occurrences across the Project in favorable rock types for uranium and Rare Earth Element (“REE”) mineralization.Ongoing Exploration: An extensive ground gravity survey is scheduled for December 2025, designed to identify density anomalies potentially representing hydrothermal alteration systems coincident with newly refined EM conductor trends across the Project. A diamond drill program is being planned for Q1 2026 to begin testing targets developed and ranked through the successful programs executed in 2025.
Michael Mulberry, Chief Executive Officer of the Company, commented “We are pleased to report verification of high-grade uranium mineralization across the Corvo Project, including assays of up to 8.10% U308 at surface. The discovery of new radioactive showings in favorable host rocks highlights the strong potential for both uranium and rare earth element mineralization across the Project. With a ground gravity survey scheduled for December and a maiden drill program planned for early 2026, we are excited to continue advancing Corvo through a data-driven exploration approach built on the success of our 2025 programs.”

2025 Prospecting Program – Geochemical Assay Results

Beginning July 4 and concluding July 16, 2025, the Standard technical team completed a detailed mapping, prospecting, and sampling program to ground-truth historical uranium showings at surface on the Project. Prospecting confirmed several uraniferous outcrops and boulders across the Project, including at the Manhattan showing (0.72% to 8.10% U3O8; Please see Figure 2).

A total of thirty (30) outcrop and boulder grab samples were submitted to Saskatchewan Research Council Geoanalytical Laboratories in Saskatoon, SK, an ISO/IEC 17025:2017 and Standards Council of Canada certified analytical laboratory, for whole-rock, uranium, and REE geochemical analysis. Uranium and Total Rare Earth Element Oxides including Yttrium oxide (TREO*) results from 28 radioactive samples are summarized below in Table 1. Oxide TREO* values in Table 1 refer to total amounts of the REE oxides in the lanthanide series plus the chemically similar element Yttrium (Y2O3). Parts per million (“ppm”) values are converted to oxide wt.% values through the applicable conversion factor relating to each REE oxide and then summed.3

Table 1. Corvo 2025 Prospecting Uranium and TREO* Geochemical Assays

SampleEastingNorthingTypeLithologyUranium
(total, ppm)U3O8
(wt.%)TREO*
(wt.%)Manhattan Showing:2449605611026408006OutcropParagneiss5,9600.7180.0412140115610996408003OutcropParagneiss32,4004.2300.1242449595611026408006OutcropParagneiss51,1005.1400.1442140105610996408003OutcropParagneiss65,7008.1000.190        2449535617036405969OutcropPegmatite15.3<0.0010.0242449555635346407318OutcropPegmatite19.7<0.0010.2932449685610226406015BoulderPegmatite101<0.0010.1212449525617446405987OutcropPegmatite150<0.0010.1272449725617866406276OutcropPegmatite23.90.0020.0092449745603826407282OutcropParagneiss2.810.0020.0232449575641506407779BoulderPegmatite40.40.0030.0082449675607836406159OutcropPegmatite22.80.0030.1142449765592946407164OutcropPegmatite92.80.0080.0232449635617866406272OutcropPegmatite43.40.0090.0102449585612886404091BoulderPegmatite1100.0120.0482449705590106405565OutcropPegmatite1190.0120.0172449655608076406127OutcropPegmatite2040.0130.0542449615611086408008OutcropParagneiss1500.0160.0552449665608076406127OutcropPegmatite68.60.0160.0722449715588166406058BoulderOrthogneiss2580.0190.0222449695582456405053BoulderPegmatite1430.0220.0892449515623486405779OutcropPegmatite2610.0220.0132449565637226407404BoulderPegmatite2910.0290.0232449545634826407023OutcropLithological Contact3630.0330.1392449735617906406254OutcropOrthogneiss2870.0340.0582449645609196405920BoulderPegmatite5750.0590.0832449755620856408020OutcropOrthogneiss8450.0950.0362449625617076406667BoulderPegmatite2,1600.2600.054

Figure 1. Regional Map of the Corvo Uranium Project

Figure 2. Manhattan Showing high-grade samples (Left) Hand sample 244959 – 5.14 wt.% U3O8 (Right) Hand sample 214010 – 8.10 wt.% U3O8. Scale bars units are metric (cm / mm).

Corvo Exploration

Supplementary geophysical surveys across the Project have been designed to further refine drill targets for an inaugural drill program in 2026. The Company will complete a high-resolution ground gravity survey across the main conductive trends on the Project, aiming to identify potential hydrothermal alteration halos which could be related to basement-hosted uranium mineralization.

Earlier this year, the Company contracted Axiom Exploration Group Ltd. in partnership with New Resolution Geophysics to carry out a helicopter-borne Xcite time domain electromagnetic and total field magnetic survey over the Project. The survey totalled approximately 1,380 line-kms with a traverse line spacing of 100 m and tie-line spacing of 1,000 m. The airborne TDEM survey outlines several kilometers of conductive anomalies and magnetic features in bedrock, effectively enhancing the resolution of more than 29 kilometres of conductive trends on the Project.

Ongoing geophysical interpretation and modeling is being completed to integrate historical surveys with newly collected datasets, which will provide high-priority drill targets and significantly derisk the Project prior to modern drilling in 2026.

The Company believes the Project is highly prospective for the discovery of shallow, high-grade basement-hosted uranium mineralization akin to the Rabbit Lake deposit and the recently discovered Gemini Mineralized Zone. Located just outside the current margin of the Athabasca Basin, Corvo boasts shallow drill targets with bedrock under minimal cover of glacial till.

Qualified Person Statement

The scientific and technical information contained in this news release has been reviewed, verified, and approved by Sean Hillacre, P.Geo., President and VP Exploration of Standard and a “qualified person” as defined in NI 43-101 – Standards of Disclosure for Mineral Projects.

Samples collected for analysis were sent to SRC Geoanalytical Laboratories in Saskatoon, Saskatchewan for preparation, processing, and ICP-MS or ICP-OES multi-element analysis using total and partial digestion and boron by fusion. Radioactive samples were tested using the ICP1 uranium multi-element exploration package plus boron. All samples marked as radioactive upon arrival to the lab were also analyzed using the U3O8 assay (reported in wt.%). SRC is an ISO/IEC 17025:2005 and Standards Council of Canada certified analytical laboratory. Blanks, standard reference materials, and repeats were inserted into the sample stream at regular intervals in accordance with Standard Uranium’s quality assurance/quality control (QA/QC) protocols. All samples passed internal QA/QC protocols and the results presented in this release are deemed complete, reliable, and repeatable.

REE oxide conversion factors3 were verified using the following formulas:

Convert REE (Rare Earth Element) ppm to REO (Rare Earth Oxide): REO % = (ppm / Atomic Weight of REE) * (Molecular Weight of REO / 10,000).

Element-to-oxide conversion factor: Molecular weight of the oxide / atomic weight of the element. For oxides with more than one metal cation, account for the number of cations in the formula. Historical data disclosed in this news release relating to sampling results from previous operators are historical in nature. Neither the Company nor a qualified person has yet verified this data and therefore investors should not place undue reliance on such data. The Company’s future exploration work may include verification of the data. The Company considers historical results to be relevant as an exploration guide and to assess the mineralization as well as economic potential of exploration projects. Any historical grab samples disclosed are selected samples and may not represent true underlying mineralization.

Natural gamma radiation from rocks reported in this news release was measured in counts per second (“cps”) using a handheld RS-125 super-spectrometer and RS-120 super-scintillometer. Readers are cautioned that scintillometer readings are not uniformly or directly related to uranium grades of the rock sample measured and should be treated only as a preliminary indication of the presence of radioactive minerals. The RS-125 and RS-120 units supplied by Radiation Solutions Inc. (“RSI”) have been calibrated on specially designed Test Pads by RSI. Standard Uranium maintains an internal QA/QC procedure for calibration and calculation of drift in radioactivity readings through three test pads containing known concentrations of radioactive minerals. Internal test pad radioactivity readings are known and regularly compared to readings measured by the handheld scintillometers for QA/QC purposes.

References

1SMDI# 2052: https://mineraldeposits.saskatchewan.ca/Home/Viewdetails/2052 & Mineral Assessment Report MAW00047: Eagle Plains Resources Inc., 2011-2012

2Standard Uranium Provides Exploration Update Highlighting Results of Gravity and TDEM Surveys on Three Eastern Athabasca Uranium Projects, News Release, March 13, 2025. https://standarduranium.ca/news-releases/standard-uranium-provides-exploration-update-tdem-surveys-on-three-eastern-athabasca-uranium/

3 https://www.jcu.edu.au/advanced-analytical-centre/resources/element-to-stoichiometric-oxide-conversion-factors

*The Company considers uranium mineralization with concentrations greater than 1.0 wt% U3O8 to be “high-grade”.

**The Company considers radioactivity readings greater than 65,535 counts per second (cps) on a handheld RS-125 Super-Spectrometer to be “off-scale”.

***The Company considers radioactivity readings greater than 300 counts per second (cps) on a handheld RS-125 Super-Spectrometer to be “anomalous”.

About Aventis Energy Inc.

Aventis Energy Inc. (CSE: AVE | FRA: C0O0 | OTC: VBAMF) is a mineral exploration company dedicated to the development of strategic projects comprised of battery, base and precious metals in stable jurisdictions. The Company is working to advance its Corvo Uranium & Sting Copper Project.

The Corvo Uranium property has historical drill holes intersected multiple intervals of uranium mineralization, notably along a strike length of 800 metres between historical drill holes TL-79-3 (0.116% U3O8 over 1.05 m) and TL-79-5 (0.065% U3O8 over 0.15 m)2. High-grade* Uranium at Surface with the Manhattan showing (1.19 to 5.98% U3O8) and SMDI showing 2052 (0.137% U3O8 and 2,300 ppm Th).

The Sting Copper Project covers approximately 12,700 hectares and recently had results of 54.8m at 0.32% Cu starting at a depth of 27.0m, with higher-grade intervals including six samples (≥0.5m length) ranging from 0.96% to 5.43% Cu. High grade samples of 0.5m at 2.85% Cu and 0.5m at 1.92% Cu with an additional broader interval of 31.1m at 0.27% Cu.

On Behalf of the Board of Directors

Michael Mulberry
Chief Executive Officer, Director
+1 (604) 229-9772
[email protected]

Disclaimer for Forward-Looking Information

This news release includes certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” under applicable Canadian securities laws. When used in this news release, the words “anticipate”, “believe”, “estimate”, expect”, “target”, “plan”, “forecast”, “may”, “would”, “could”, “schedule” and similar words or expressions, identify forward-looking statements or information.

Forward-looking statements and forward-looking information relating to any future mineral production, liquidity, enhanced value and capital markets profile of Aventis, future growth potential for Aventis and its business, and future exploration plans are based on management’s reasonable assumptions, estimates, expectations, analyses and opinions, which are based on management’s experience and perception of trends, current conditions and expected developments, and other factors that management believes are relevant and reasonable in the circumstances, but which may prove to be incorrect. Assumptions have been made regarding, among other things, the price of uranium, copper, gold and other metals; costs of exploration and development; the estimated costs of development of exploration projects; Aventis’ ability to operate in a safe and effective manner and its ability to obtain financing on reasonable terms.

This news release contains “forward-looking information” within the meaning of the Canadian securities laws. Statements, other than statements of historical fact, may constitute forward looking information and include, without limitation, statements with respect to the Project and its mineralization potential; the Company’s objectives, goals, or future plans with respect to the Project; and the Company's anticipated exploration program at the Project. With respect to the forward-looking information contained in this news release, the Company has made numerous assumptions regarding, among other things, the geological, metallurgical, engineering, financial and economic advice that the Company has received is reliable and are based upon practices and methodologies which are consistent with industry standards. While the Company considers these assumptions to be reasonable, these assumptions are inherently subject to significant uncertainties and contingencies. Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. Known risk factors include, among others: fluctuations in commodity prices and currency exchange rates; uncertainties relating to interpretation of well results and the geology, continuity and grade of uranium, copper, gold and other metal deposits; uncertainty of estimates of capital and operating costs, recovery rates, production estimates and estimated economic return; the need for cooperation of government agencies in the exploration and development of properties and the issuance of required permits; the need to obtain additional financing to develop properties and uncertainty as to the availability and terms of future financing; the possibility of delay in exploration or development programs or in construction projects and uncertainty of meeting anticipated program milestones; uncertainty as to timely availability of permits and other governmental approvals; increased costs and restrictions on operations due to compliance with environmental and other requirements; increased costs affecting the metals industry and increased competition in the metals industry for properties, qualified personnel, and management. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

The Canadian Securities Exchange (CSE) does not accept responsibility for the adequacy or accuracy of this release.

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/397c8113-5f1a-4dea-b396-d0efc57e6b1d
https://www.globenewswire.com/NewsRoom/AttachmentNg/fd83e363-bcb4-411e-81de-708ef5eb44be
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
PMGC Holdings Inc. Announces Over $711,000.00 in Sales Backlog at AGA Precision Systems LLC and Provides Corporate Update stocknewsapi
ELAB
NEWPORT BEACH, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company” or “we”), a diversified public holding company executing a targeted roll-up strategy in U.S.-based manufacturing, today announced that its operating subsidiary AGA Precision Systems LLC (“AGA”) has reported a sales backlog of approximately over $711,000 in current orders logged into its Material Requirements Planning system, Sage100.
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025 stocknewsapi
BCTX
October 20, 2025 07:30 ET

 | Source:

BriaCell Therapeutics Corp.

Biomarkers identified in BriaCell’s Phase 2 study are showing similar and encouraging trends in the ongoing pivotal Phase 3 study of Bria-IMT™ in metastatic breast cancer (MBC)No new safety or tolerability issues identified in pooled analysis of ongoing pivotal Phase 3 study PHILADELPHIA and VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces encouraging clinical biomarker data in its ongoing pivotal Phase 3 study of Bria-IMT plus an immune check point inhibitor (CPI) in metastatic breast cancer. The findings are being presented in BriaCell’s poster presentation at the European Society for Medical Oncology (ESMO) Congress 2025 Annual Meeting taking place October 17 – 21, 2025 in Berlin, Germany. The Phase 3 data shown is for all patients evaluated regardless of treatment assignment (i.e. is blinded).

“We are encouraged by the early constructive clinical biomarker data which could allow us to predict clinical and survival outcomes in our patients and would help guide treatment decisions for metastatic breast cancer patients with limited options,” stated Dr. William V. Williams, BriaCell’s President and CEO.

Poster #3928: Feasibility and Biomarker Validation of an International Randomized Phase 3 Trial of Bria-IMT Cell Therapy in Late Stage MBC (BRIA-ABC)

In BriaCell’s pivotal Phase 3 study of Bria-IMT plus an immune check point inhibitor (CPI) in metastatic breast cancer, patients are randomized 1:1:1 to Bria-IMT + CPI, Treatment of Physician’s Choice, or Bria-IMT monotherapy. As of the time of the poster submission, pooled data was available in 113 patients, with a median of 6 prior lines of treatment (2–13). Evaluable only pertains to imaging. All 113 are evaluated for safety, PFS, etc.

As reported in the Phase 2 study, Neutrophil to Lymphocyte Ratio (NLR) continues to be a potential biomarker of clinical benefit as progression free survival (PFS) was significantly higher in patients with NLR of 0.7 – 2.3 (4.5 months) vs those with NLR < 0.7 or > 2.3 (2.5 months) {(HR) of 0.5 (95% CI 0.3–0.8, p=0.005)}.

In the Phase 3 study, PFS data comparing BriaCell’s Bria-IMT combination regimen versus those treated with physician’s choice remains blinded at this time. Bria-IMT has been well tolerated in the Phase 3 study with no treatment-related discontinuations due to adverse events (AEs). The most common AEs are minor, including fatigue, anemia, and nausea.

About BriaCell’s Pivotal Phase 3 Clinical Study of Bria-IMT Combination Regimen in MBC patients

BriaCell’s pivotal Phase 3 study of Bria-IMT plus an immune check point inhibitor (CPI) in metastatic breast cancer is ongoing.

Interim data will be analyzed once 144 patient events (deaths) occur, comparing the overall survival (OS) in patients treated with the Bria-IMT combination regimen versus those treated with physician’s choice as the primary endpoint. Positive results of the pivotal Phase 3 study could result in full approval and marketing authorization for Bria-IMT in MBC patients. BriaCell reported positive Phase 2 survival data in a similar MBC patient population treated with the same Bria-IMT combination regimen. The Bria-IMT combination regimen has received FDA Fast Track designation.

For additional information on BriaCell’s pivotal Phase 3 study of Bria-IMT and an immune check point inhibitor in metastatic breast cancer, please visit ClinicalTrials.gov NCT06072612.

A copy of the poster presentation is posted on https://briacell.com/scientific-publications/.

About BriaCell Therapeutics Corp.

BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available at https://briacell.com/.

Safe Harbor

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements, including: BriaCell's plans to present clinical data presentations at the ESMO Congress 2025, and the contents of all such presentations; BriaCell's statements regarding early constructive clinical biomarker data allowing the Company to predict clinical and survival outcomes and guide treatment decisions for metastatic breast cancer patients; and the Company's anticipated timing of analysis of interim data are based on BriaCell’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading “Risks and Uncertainties” in the Company's most recent Management’s Discussion and Analysis, under the heading "Risk Factors" in the Company's most recent Annual Information Form, and under “Risks and Uncertainties” in the Company's other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under the Company's profiles on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law.

Neither the Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

Company Contact:
William V. Williams, MD
President & CEO
1-888-485-6340
[email protected] 

Investor Relations Contact:
[email protected]
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Blaqclouds, Inc. Applies for FinCEN Registration as a Money Services Business (MSB) and Initiates Share Audit Following Management Transition stocknewsapi
BCDS
ROBESONIA, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Blaqclouds, Inc., a Nevada corporation (OTC: BCDS), today announced that it has officially submitted its application to the U.S. Department of the Treasury's Financial Crimes Enforcement Network (FinCEN) to register as a Money Services Business (MSB) under the Bank Secrecy Act (BSA). While the application has been formally accepted, the company anticipates receiving its BSA ID within the next two weeks, marking a major milestone in its pursuit of full regulatory compliance and financial transparency.

“Registering as a Money Services Business with FinCEN represents a critical step forward in aligning our Web3 payment technologies with existing U.S. compliance frameworks,” said Shannon Hill, CEO of Blaqclouds, Inc. “This filing allows us to continue building decentralized financial infrastructure with the safeguards expected of regulated institutions.”

Initiation of Share Audit and Legal Review Post-Management Change

In conjunction with the FinCEN filing, Blaqclouds has also launched a comprehensive audit of all common stock transactions and share issuances that occurred during the period of April 2025 through October 7, 2025. This action follows the re-acquisition of control of the company by new management on October 7, 2025, a turning point for the integrity and strategic direction of Blaqclouds.

Key audit details include:

The original acquisition of Blaqclouds occurred in November 2024, at which time the total outstanding share count was fewer than 400 million shares, of which the prior CEO personally held 250 million shares.During the disputed period between April and October 2025, the previous CEO: Canceled their own 250 million common shares,Increased the authorized share count to 1 billion shares, andIssued over 650 million shares through alleged 3rd-party debt conversions. During the Company’s initial review, it was determined that two Notices of Conversion—each resulting in the issuance of 87 million shares, totaling 174 million shares—may have been executed without valid legal authority. The Company has formally notified its transfer agent to begin the process of investigating and correcting these irregularities. “We need to determine if these actions were taken with proper shareholder approval, legal board authorization and required public disclosure,” said Shannon Hill. “Our legal team is currently reviewing all associated instruments and has been instructed to initiate cancellations and pursue litigation, if necessary, to safeguard the integrity of our capital structure and protect the interests of our legitimate shareholders.”

Commitment to Transparency and Compliance

Dominion Stock Transfer is Blaqclouds official transfer agent and is working closely with the Company to reconcile and validate all share issuances during the disputed period. Once the audit is complete, the company will publicly disclose the findings and update its shareholder records accordingly.

With the FinCEN MSB registration process underway and a thorough legal and financial review in progress, Blaqclouds continues to demonstrate its commitment to operating as a trustworthy and fully transparent Web3 financial services company.

About Blaqclouds, Inc.

Blaqclouds bridges legacy finance with decentralized networks, creating seamless, real-world blockchain solutions that unify commerce and payments. Its mission is to make spending crypto as easy, trusted, and useful as cash.

Flagship consumer applications include:
- ShopWithCrypto.io – Crypto-to-gift card commerce
- ZEUSxPay.io – Web3 payment infrastructure
- DEX.ZEUSx.io – EVM-native decentralized exchange
- ApolloWallet.io – Secure, consumer-grade blockchain wallet

A full list of Blaqclouds WY and NV platforms can be found at: www.blaqclouds.io

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve certain risks and uncertainties that may cause actual results to differ materially. Blaqclouds, Inc. assumes no obligation to update or revise any forward-looking statements.

Media Contact
Blaqclouds, Inc.
c/o theAlley.io
Email: [email protected]
Phone: 307-323-4430
Website: www.blaqclouds.io
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
CorMedix Inc. Announces Preliminary Third Quarter 2025 Results and Raises 2025 Net Revenue Guidance stocknewsapi
CRMD
October 20, 2025 07:30 ET

 | Source:

CorMedix, Inc.

‒ Q3 2025 Unaudited Pro Forma Net Revenue of more than $125 million ‒

‒ Q3 2025 Unaudited DefenCath Net Revenue of more than $85 million ‒

‒ Raising FY 2025 Pro Forma Net Revenue Guidance to at least $375 million ‒

‒ ~$30mm of operating synergy on a go-forward run-rate basis before year end 2025 ‒

BERKELEY HEIGHTS, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced selected preliminary unaudited third quarter results and provided an update on its business. These include the following key updates:

Preliminary Q3 2025 unaudited net revenue of more than $100 million, including at least $85 million for DefenCath, and preliminary pro forma Q3 2025 unaudited Company net revenue of more than $125 million(1). DefenCath revenue growth has been driven by stronger than projected utilization by the Company’s LDO customer as well as continued utilization growth with other customers.Based on the current sales trend for DefenCath as well as the performance of the recently acquired Melinta portfolio, CorMedix is increasing its full-year 2025 pro forma net revenue guidance from the previously announced range of $325-$350 million to at least $375 million(1). Company expects Q3 2025 adjusted EBITDA(2) of at least $70 million.The Company has made significant progress on the integration of Melinta and management now forecasts cost synergy capture of at least $30 million on a go-forward run-rate basis before the end of the fourth quarter 2025, with the remaining targeted synergies of $5 – $15 million expected to be captured in CY 2026. CorMedix recently announced the completion of enrollment in the ongoing Phase III ReSPECT study of Rezzayo in prophylaxis of fungal infection in adult patients undergoing allogeneic blood and marrow transplant. The Company expects to be able to share clinical data in 2Q 2026 and believes that the total addressable market for prophylaxis is more than $2 billion.Cash, cash equivalents and short-term investments as of September 30, 2025 accounted for approximately $56 million, and the Company is guiding to a projected year end cash and cash equivalent balance of approximately $100 million.   The Company’s Q3 cash balance was impacted by cash payments made for the acquisition of Melinta and associated closing costs, the Company’s strategic investment in Talphera, as well as increased working capital requirements necessary to support revenue growth.
The preliminary financial information presented in this press release is based on CorMedix’s current expectations and may be adjusted as a result of, among other things, the completion of the quarterly review procedures of CorMedix’s third quarter 2025 financial statements.

Q3 2025 unaudited pro forma net revenue was prepared by combining the estimated financial results for CorMedix and Melinta for the full fiscal quarter ended September 30, 2025, as if the transaction had closed as of the first day of the fiscal quarter. Pro Forma 2025 Net Revenue guidance was prepared by combining the estimated financial results and guidance for CorMedix and Melinta for the full fiscal year ended December 31, 2025, without further adjustment, as if the transaction had closed on January 1, 2025.Adjusted EBITDA is a non-GAAP financial measure and excludes non-cash items such as stock-based compensation and certain non-recurring items. The Company expects to provide a reconciliation of Adjusted EBITDA to the most comparable GAAP measure in its earnings release relating to the third quarter 2025 financial results. Such reconciliation is not included in this release because the Company is currently finalizing certain amounts that would be required to be included in the U.S. GAAP measure or the individual adjustments for such reconciliation.
About CorMedix

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. CorMedix is commercializing DefenCath® (taurolidine and heparin) for the prevention of catheter-related bloodstream infections in adult patients undergoing hemodialysis via a central venous catheter. Following its August 2025 acquisition of Melinta Therapeutics LLC, CorMedix is also commercializing a portfolio of anti-infective products, including MINOCIN® (minocycline), REZZAYO® (rezafungin), VABOMERE® (meropenem and vaborbactam), ORBACTIV™ (oritavancin), BAXDELA® (delafloxacin), and KIMYRSA® (oritavancin), as well as TOPROL-XL® (metoprolol succinate).

CorMedix has ongoing clinical studies for DefenCath in Total Parenteral Nutrition and Pediatric patient populations and also intends to develop DefenCath as a catheter lock solution for use in other patient populations. REZZAYO is currently approved for the treatment of candidemia and invasive candidiasis in adults, with an ongoing Phase III study for the prophylaxis of IFD in adult patients undergoing allogeneic BMT. Topline results of the Phase III study for REZZAYO are expected in Q2 2026. For more information visit: www.cormedix.com or www.melinta.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Exchange, as amended (the “Exchange Act”), that are subject to risks and uncertainties. Forward-looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “will,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would,” and similar expressions or variations intended to identify forward-looking statements. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or CorMedix’s prospects should be considered forward-looking statements including, but not limited to statements regarding financial guidance, peak annual sales estimates, synergy estimates and timing, accretion estimates and Adjusted EBITDA estimates. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, and readers are directed to the Risk Factors identified in CorMedix’s filings with the SEC, including its most recent Annual Report on Form 10-K, copies of which are available free of charge at the SEC’s website at www.sec.gov or upon request from CorMedix and in the Quarterly Report on Form 10-Q for the quarter ended, on June 30, 2025. CorMedix may not actually achieve the goals or plans described in its forward-looking statements, and such forward-looking statements speak only as of the date of this press release. In addition, pro forma financial information does not necessarily reflect the actual results that we would have achieved had the pro forma transaction been consummated as of the date indicated nor does it reflect the potential future results of the combined company. Investors should not place undue reliance on these statements. CorMedix assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
[email protected]
(617) 430-7576
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
ITURAN LOCATION AND CONTROL LTD. SCHEDULES THIRD QUARTER 2025 RESULTS RELEASE AND CONFERENCE CALL FOR NOVEMBER 18, 2025 stocknewsapi
ITRN
Conference Call Scheduled at 9am Eastern Time

, /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN), announced that it will be releasing its third quarter 2025 results on Tuesday, November 18, 2025.

The Company will be hosting a video conference call later that day via Zoom, starting at 9am Eastern Time, 6am Pacific Time and 4pm Israel time. On the call, management will review and present the results and will be available to answer investor questions.

To participate in the Zoom call, please register at the following link: 
https://us06web.zoom.us/webinar/register/WN_v7fBVdwwT-KnDOQ7OfgoBA#/registration

Following registration, you will be sent the link to the conference call which is accessible either via the Zoom app, or alternatively from a dial-in telephone number. If you have an issue with registration, please contact the Ituran investor relations team, well in advance of the call.

For those unable to participate, the call will be available for replay through the same link, or from a link to the recording on Ituran's website, beginning within a few hours following the end of the call.

About Ituran

Ituran is a leader in the emerging mobility technology field, providing value-added location-based services, including a full suite of services for the connected-car. Ituran offers Stolen Vehicle Recovery, fleet management as well as mobile asset location, management & control services for vehicles, cargo and personal security for the retail, insurance, financing industries and car manufacturers. Ituran is the largest OEM telematics provider in Latin America. Its products and applications are used by customers in over 20 countries. Ituran is also the founder of the Tel-Aviv based DRIVE startup incubator to promote the development of smart mobility technology.

Ituran's subscriber base has been growing significantly since the Company's inception to over 2.5 million subscribers using its location-based services with a market leading position in Israel and Latin America. Established in 1995, Ituran has approximately 2,800 employees worldwide, with offices in Israel, Brazil, Argentina, Mexico, Ecuador, Columbia, India, Canada and the United States.

For more information, please visit Ituran's website, at: www.ituran.com

Company Contact

Udi Mizrahi

Deputy CEO and VP Finance, Ituran

[email protected]

(Israel) +972 3 557 1348

International Investor Relations

Ehud Helft

EK Global Investor Relations

[email protected]

(US) +1 212 378 8040   

Logo - https://mma.prnewswire.com/media/1972820/Ituran_logo.jpg

SOURCE Ituran Location and Control Ltd.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 stocknewsapi
PROK
October 20, 2025 07:30 ET

 | Source:

ProKidney

WINSTON-SALEM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company will present two posters, including a late-breaking poster on the Phase 2 REGEN-007 study results, at the upcoming American Society of Nephrology’s (ASN) Kidney Week being held from November 6-9, 2025, in Houston, TX.

The titles for the accepted abstracts are provided below and accessible online at: https://www.asn-online.org/education/kidneyweek/2025/program-search-abstract.aspx

Late-Breaking Poster Presentation

Renal Autologous Cell Therapy in Diabetes and CKD (Phase 2 REGEN-007 Study Results)
Session Title: Late-Breaking Science Posters [LB-PO]
Session Date, Time: November 6, 2025 from 10:00 AM to 12:00 PM CST
Poster Board #: TH-PO1203

Other Poster Presentation

Cell-Specific Inflammatory Profile Characterization of the Cell Therapy Candidate Rilparencel
Session Title: Development, Stem Cells, and Regenerative Medicine [PO0600]
Session Date, Time: November 6, 2025 from 10:00 AM to 12:00 PM CST
Poster Board #: TH-PO0575

Following the event, a copy of the poster presentations will be available on the Company’s website at: https://prokidney.com/our-technology/publications/

Additional information on ASN Kidney Week 2025 can be accessed online at:
https://www.asn-online.org/education/kidneyweek

About ProKidney Corp.
ProKidney, a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, rilparencel (also known as REACT®), is a first-in-class, patented, proprietary autologous cellular therapy with regenerative medicine advanced therapy designation that is being evaluated in the ongoing Phase 3 REGEN-006 (PROACT 1) study for its potential to preserve kidney function in patients with advanced CKD and type 2 diabetes. For more information, please visit www.prokidney.com.

ProKidney Contact
Ethan Holdaway
[email protected]

Media Contact
Audra Friis 
[email protected]

Investor Relations Contact
Daniel Ferry
[email protected]
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Lantronix Unveils Kompress.ai by Lantronix, an AI-Powered Platform That Optimizes Performance in Energy-Intensive Industries Using Vodafone IoT's Connectivity stocknewsapi
LTRX
IRVINE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, and Vodafone IoT, a global leader in managed IoT connectivity services, today announced a partnership to help businesses optimize performance and unlock recurring revenue in energy-intensive industries. Available this fall in the United States and Canada, Kompress.ai by Lantronix is a turnkey, brand-agnostic AI-powered subscription platform designed to transform the $27 billion+ global industrial air compressor market by cutting costs, reducing downtime and enabling sustainability compliance. The platform combines Lantronix’s Edge hardware and cloud intelligence with Vodafone’s global IoT connectivity to deliver real-time insights and automation for compressor fleets.

Kompress.ai by Lantronix represents a major expansion of Lantronix’s recurring revenue model and critical infrastructure strategy, building on its success in the generator segment. By combining Lantronix Edge hardware with Kompress.ai cloud-based intelligence and Vodafone IoT’s global cellular IoT connectivity, the platform delivers predictive analytics, energy optimization and compliance automation for industrial air compressor fleets of any brand or age.

Delivers Strong ROI in a Fast-Growth Industry

Kompress.ai by Lantronix provides opportunities for strong ROI in the fast-growth air compressor industry, delivering:

Market Opportunities: The air compressor sector presents growth potential in both brownfield upgrades and greenfield projects, driven by industrial automation trends and evolving sustainability initiatives.Strong ROI for Customers: Kompress.ai by Lantronix has demonstrated energy savings of up to 30 percent while reducing unplanned downtime and decreasing service costs, making it a mission-critical solution for cost-conscious industrial buyers.Recurring Revenue Model: Offered via subscription, Kompress.ai by Lantronix is expected to contribute to Lantronix’s recurring revenue stream, enhancing the predictability of its business model.Strategic Vodafone IoT Partnership: Deployment and scalability are enabled via Vodafone’s secure, reliable and compliant IoT connectivity, positioning the platform for fast rollout.Sustainability & Compliance Differentiation: As corporations face rising energy costs and stricter ESG mandates, Kompress.ai by Lantronix is designed to support ISO 50001 compliance and CO₂ emissions reduction goals, helping customers achieve sustainability KPIs. A Next-Gen Platform for Industrial IoT

Kompress.ai by Lantronix is built to address one of the most significant energy loads in industrial environments — air compressors — which account for 10 percent or more of electricity use and 4.3 million tons of CO₂ emissions annually. With real-time insights and AI-powered optimization, Kompress.ai helps operators meet both operational and environmental performance goals.

"Kompress.ai by Lantronix is a scalable SaaS solution designed to generate long-term, high-margin recurring revenue while addressing urgent market needs in industrial efficiency and sustainability," said Mathi Gurusamy, Chief Strategy Officer at Lantronix. “This platform expands our total addressable market and aligns with global energy and ESG trends that are reshaping enterprise purchasing priorities.”

“This is more than just an asset monitoring tool — it’s a platform that brings data, intelligence and action together at the Edge,” added Gurusamy. “It positions Lantronix at the intersection of AI, sustainability and industrial automation.”

Dennis Nikles, managing director at Vodafone IoT Americas, said, “Our partnership with Lantronix is a testament to how IoT connectivity can accelerate digital transformation across critical infrastructure. Industrial OEMs and operators now have a turnkey solution that improves operational resilience while supporting global sustainability goals.”

Lantronix will be exhibiting at the Best Practices Expo 2025 on October 21–23 and will be showcasing the Kompress.ai by Lantronix platform. For more information, visit www.lantronix.com.

About Lantronix   

Lantronix Inc. (Nasdaq: LTRX) is a global leader in Edge AI and Industrial IoT solutions, delivering intelligent computing, secure connectivity, and remote management for mission-critical applications. Serving high-growth markets, including smart cities, enterprise IT, and commercial and defense unmanned systems, Lantronix enables customers to optimize operations and accelerate digital transformation. Its comprehensive portfolio of hardware, software, and services powers applications from secure video surveillance and intelligent utility infrastructure to resilient out-of-band network management. By bringing intelligence to the network edge, Lantronix helps organizations achieve efficiency, security, and a competitive edge in today’s AI-driven world.

Kompress.ai is a trademark used under exclusive license by Lantronix Inc.

For more information, visit the Lantronix website.

About Vodafone IoT

Vodafone IoT is a global leader in managed IoT connectivity services. With over 215 million devices connected across more than 180 countries, we provide businesses with reliable and secure IoT solutions, enabling them to effectively manage, monitor, and operate their IoT devices.

Our extensive network partnerships, spanning over 760 networks worldwide, allows us to deliver global IoT solutions that empower businesses to digitalise, transform and maximise the benefits of IoT.

By adopting IoT, businesses can benefit from smarter resource management, reducing emissions, and enhancing operational efficiency – helping them to operate more sustainably.

For more information, please visit Vodafone IOT, follow us on X at @VodafoneIoT or connect with us on LinkedIn at www.linkedin.com/company/vodafoneIoT.

©2025 Lantronix, Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking statements within the meaning of federal securities laws, including, without limitation, statements related to Lantronix products or leadership team. These forward-looking statements are based on our current expectations and are subject to substantial risks and uncertainties that could cause our actual results, future business, financial condition, or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this news release. The potential risks and uncertainties include, but are not limited to, such factors as the effects of negative or worsening regional and worldwide economic conditions or market instability on our business, including effects on purchasing decisions by our customers; our ability to mitigate any disruption in our and our suppliers’ and vendors’ supply chains due to the COVID-19 pandemic or other outbreaks, wars and recent tensions in Europe, Asia and the Middle East, or other factors; future responses to and effects of public health crises; cybersecurity risks; changes in applicable U.S. and foreign government laws, regulations, and tariffs; our ability to successfully implement our acquisitions strategy or integrate acquired companies; difficulties and costs of protecting patents and other proprietary rights; the level of our indebtedness, our ability to service our indebtedness and the restrictions in our debt agreements; and any additional factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025, filed with the Securities and Exchange Commission (the “SEC”) on Aug. 29, 2025, including in the section entitled “Risk Factors” in Item 1A of Part I of that report, as well as in our other public filings with the SEC. Additional risk factors may be identified from time to time in our future filings. In addition, actual results may differ as a result of additional risks and uncertainties about which we are currently unaware or which we do not currently view as material to our business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules of the Nasdaq Stock Market LLC. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.

Lantronix Media Contact:         
[email protected] 
949-212-0960 

Lantronix Analyst and Investor Contact:         
[email protected]

Vodafone Media Relations:
Vodafone.com/media/contact
[email protected]

Vodafone Investor Relations:
Investors.vodafone.com
[email protected]

Vodafone Registered Office:
Vodafone House, The Connection, Newbury
Berkshire RG14 2FN, England.
Registered in England No. 1833679
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Press Release: Sanofi's Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program stocknewsapi
SNY
Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program

If approved, Tzield would be the first disease-modifying therapy to delay the progression of stage 3 T1D in adults and pediatric patients eight years of age and older recently diagnosed with stage 3 T1DTzield is also being reviewed under the accelerated approval program Paris, October 20, 2025. The US Food and Drug Administration (FDA) has accepted for expedited review the supplemental biologics license application (sBLA) for Tzield (teplizumab-mzwv) to delay the progression of stage 3 type 1 diabetes (T1D) in adults and pediatric patients eight years of age and older recently diagnosed with stage 3 T1D. The FDA nominated Tzield for the Commissioner's National Priority Voucher (CNPV) pilot program based on its potential to address a large unmet medical need. The CNPV program aims to shorten the review process from what normally takes 10-12 months to 1-2 months, while maintaining FDA's rigorous safety and efficacy standards.

"We welcome that Tzield has been accepted for expedited review by the FDA under the Commissioner’s National Priority Voucher pilot program, potentially enabling us to go further and faster for patients and lead the way with breakthrough science," said Olivier Charmeil, Executive Vice President, General Medicines, Sanofi. "This is a recognition of the breakthrough innovative profile of Tzield, its ability to potentially prevent the natural progression of T1D, and the significant unmet medical need that remains in this area which has seen limited treatment advances in the last 100 years.”

The sBLA is supported by the results from the PROTECT phase 3 study, which met its primary endpoint, evaluating preservation of beta cell function as assessed by significantly slowing the decrease in mean C-peptide levels (area under the curve [AUC] after a four-hour mixed meal tolerance test) at trial study completion, compared to placebo. Additionally, the sBLA builds on the clinical development program of Tzield including approximately~1,000 patients.

Adverse events observed in the PROTECT phase 3 study were consistent with previous studies. Most common adverse events were headache, nausea, rash, lymphopenia, leukopenia and gastrointestinal symptoms, consistent with the mode of action of cytokine release. 1.8% of those who received Tzield in the PROTECT study developed cytokine release syndrome possibly or probably related to Tzield.

Additionally, Tzield is being reviewed under the accelerated approval program, a pathway that allows the FDA to review therapies intended to treat serious conditions that fill an unmet medical need, based on a surrogate endpoint reasonably likely to predict clinical benefit. In line with this requirement, the confirmatory BETA-PRESERVE phase 3 study (clinical study identifier: NCT07088068) was initiated recently and is currently enrolling participants.

Tzield is approved in the US, the UK, China, Canada, Israel, the Kingdom of Saudi Arabia, the United Arab Emirates, and Kuwait to delay the onset of stage 3 T1D in adults and pediatric patients eight years and older diagnosed with stage 2 T1D. Regulatory reviews are ongoing in the EU and other jurisdictions around the world. Tzield was previously designated by the FDA as Breakthrough Therapy and was granted orphan drug designation, for investigational medicines that treat rare diseases affecting fewer than 200,000 people in the US.

The safety and efficacy of Tzield in stage 3 T1D have not yet been approved by any regulatory authority.

About PROTECT
PROTECT (clinical study identifier: NCT03875729) was a phase 3, randomized, double blind, placebo-controlled, multi-national study. It enrolled 328 children and adolescents (Tzield n=217, placebo n=111) aged eight-17 years diagnosed with clinical, stage 3 T1D in the preceding six weeks; randomization ratio of Tzield to placebo was 2:1. Participants received a first course of 12 daily infusions (of either Tzield or placebo) at randomization, followed by a second course of 12 daily infusions after 26 weeks (approx. six months). All participants received standard-of-care medicines as required.

The primary objective of PROTECT was to determine whether Tzield could preserve beta cell function measured by C-peptide, compared to placebo. This was assessed via the trial’s primary endpoint, which measured the difference in mean change of C-peptide level (area under the time-concentration curve [AUC] measured after a four-hour mixed meal tolerance test) from baseline to Week 78 between both groups.

Key secondary endpoints included change in HbA1c, time in range as measured with a CGM, clinically important low blood sugar (hypoglycemia) events and exogenous insulin use. Time in range was defined as: ≥ 70 but ≤180 mg/dL. Clinically relevant hypoglycemic events were defined: level 2 hypoglycemia (<54 mg/dL / 3.0 mmol/L) and level 3 hypoglycemia as episodes of severe cognitive impairment requiring external assistance for recovery, even in the absence of a blood glucose reading.

Other secondary endpoints were adverse events and overall safety aspects, as well as pharmacokinetics and immunogenicity of Tzield. An observational extension study following participants for a further 42 months is ongoing.

About Tzield
Tzield (teplizumab-mzwv) is a CD3-directed monoclonal antibody. Tzield is the first and only disease modifying therapy in autoimmune T1D; it was approved in the US in November 2022 to delay the onset of Stage 3 type 1 diabetes in adults and children eight years and older diagnosed with stage 2 T1D. Today, it is also approved in the UK, China, Canada, Israel, the Kingdom of Saudi Arabia, the United Arab Emirates, and Kuwait for the same indication. Regulatory reviews are ongoing in the EU and other jurisdictions around the world.

About autoimmune T1D
T1D is a progressive autoimmune condition where the body’s ability to regulate blood sugar levels is impacted due to the gradual destruction of insulin producing beta cells by one’s own immune system. There are four stages to the progression of T1D:

In stage 1, the autoimmune attack to the beta cells has started, and this can be detected by the presence of 2 or more T1D-related autoantibodies in the blood. During stage 1, blood sugar levels are in a normal range (normoglycemia). At this stage, T1D is presymptomatic.In stage 2 (also presymptomatic), in addition to the presence of 2 or more T1D-related autoantibodies, blood sugar levels are now abnormal (dysglycemia) due to the progressive loss of beta cells / beta cell function. Stage 3 (also known as clinical stage) comes once a significant portion of the beta cells have been destroyed. At this point, rising blood sugar levels reach the point of clinical hyperglycemia (which defines diabetes), and many people will start to experience the classic symptoms that come with the onset of stage 3 T1D: increased thirst, frequent urination, unexplained weight loss, blurred vision, and generalized fatigue. Management of stage 3 T1D requires daily and burdensome insulin replacement therapy.Stage 4 is defined as long-standing autoimmune T1D, often accompanied by evidence of chronic diabetic complications, where little to no beta-cell function remain (it’s been estimated that beta-cell mass is reduced by up to 95%). At this point, the T1D-related autoantibodies might not be present anymore in the blood, as most beta-cells have been rendered useless by the autoimmune attack. About Sanofi
Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.

Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

Media Relations
Sandrine Guendoul | +33 6 25 09 14 25 | [email protected]
Evan Berland | +1 215 432 0234 | [email protected]  
Léo Le Bourhis | +33 6 75 06 43 81 | [email protected]  
Victor Rouault | +33 6 70 93 71 40 | [email protected]
Timothy Gilbert | +1 516 521 2929 | [email protected]
Léa Ubaldi | +33 6 30 19 66 46 | [email protected]

Investor Relations
Thomas Kudsk Larsen | +44 7545 513 693 | [email protected]  
Alizé Kaisserian | +33 6 47 04 12 11 | [email protected]
Felix Lauscher | +1 908 612 7239 | [email protected]  
Keita Browne | +1 781 249 1766 | [email protected]
Nathalie Pham | +33 7 85 93 30 17 | [email protected]
Tarik Elgoutni | +1 617 710 3587 | [email protected]  
Thibaud Châtelet | +33 6 80 80 89 90 | [email protected]
Yun Li | +33 6 84 00 90 72 | [email protected]

Sanofi forward-looking statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation,  trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2024. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

All trademarks mentioned in this press release are the property of the Sanofi group. 

Press Release
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Altimmune to Present Phase 2b IMPACT Data on Pemvidutide in MASH in Late-Breaking Oral Podium Presentation and Late-Breaking Poster at AASLD The Liver Meeting® 2025 stocknewsapi
ALT
October 20, 2025 07:30 ET

 | Source:

Altimmune, Inc

Oral presentation to highlight 24-week efficacy and safety data

Poster to feature results of AI-based analyses of liver fibrosis reduction

GAITHERSBURG, Md., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that 24-week data from its Phase 2b IMPACT trial of pemvidutide in metabolic dysfunction-associated steatohepatitis (MASH) will be presented in late-breaking oral and poster presentations at The Liver Meeting® 2025, hosted by the American Association for the Study of Liver Diseases (AASLD) in Washington, D.C., November 7–11, 2025.

Details of the presentations are as follows:

Poster Presentation Details

Abstract Title: Reduction of Liver Fibrosis by AI-Based Digital Pathology Analysis: Results from the Pemvidutide Phase 2 IMPACT TrialSession: Saturday Late-Breaking Posters (publication number 5025)Date/Time: The presenter will present/take questions during Poster Session II on Saturday, November 8, 2025 from 1:00 – 2:00 p.m. ET. The poster will be on display throughout The Liver Meeting®Presenter: Dr. Julio Gutierrez, Transplant Hepatologist at the Scripps Organ and Cell Transplant Program and Senior Medical Director at Altimmune Oral Presentation Details

Abstract Title: A Phase 2, Multicenter, Randomized, Placebo-Controlled Trial of Pemvidutide in Metabolic Dysfunction-Associated SteatohepatitisSession: Late-Breaking Abstracts Parallel Session 3 (publication number 5001)Date/Time: Tuesday, November 11, 2025 at 11:45 a.m. ETPresenter: Dr. Mazen Noureddin, Professor of Medicine at the Houston Methodist Hospital and Co-Chairman of the Board for Summit and Pinnacle Clinical Research The AASLD late-breaking presentations will focus on the recent IMPACT Phase 2b readout of the 24-week data. In addition, Altimmune expects to announce 48-week data in Q4 2025.

A copy of the presentation and poster will be accessible on the Events section of the Altimmune website.

About the Phase 2b IMPACT Study

The IMPACT (NCT05989711) trial enrolled 212 participants with biopsy-confirmed MASH and fibrosis stages F2/F3 with and without diabetes randomized 1:2:2 to receive weekly subcutaneous pemvidutide doses at either 1.2 mg, 1.8 mg, or placebo for 24 weeks. Key efficacy endpoints were MASH resolution without worsening of fibrosis, or fibrosis improvement without worsening of MASH at 24 weeks. Secondary endpoints included weight loss and non-invasive tests of fibrosis. Participants will receive a total of 48 weeks of treatment, and a final readout is anticipated in the fourth quarter of 2025.

About Pemvidutide

Pemvidutide is a novel, investigational, peptide-based 1:1 GLP-1/glucagon dual receptor agonist in development for the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), Alcohol Use Disorder (AUD), and Alcohol-Associated Liver Disease (ALD). The combined activation of GLP-1 and glucagon receptors results in appetite suppression, weight loss, and direct effects on the liver, including reductions in liver fat, inflammation and fibrosis. The FDA granted Fast Track designations to pemvidutide for the treatment of MASH and AUD, both areas of significant unmet medical need. The 48-week readout from the ongoing IMPACT Phase 2b MASH trial is expected in Q4 2025. Phase 2 trials in AUD (RECLAIM) and ALD (RESTORE) were initiated in May 2025 and July 2025, respectively and are currently ongoing.

About Altimmune

Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of MASH, Alcohol Use Disorder (AUD), Alcohol-associated Liver Disease (ALD) and obesity. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on X

Investor Contact:
Lee Roth
Burns McClellan
Phone: 646-382-3403
[email protected]

Media Contact:
Elliot Fox
Real Chemistry
[email protected]

This press release was published by a CLEAR® Verified individual.
2025-10-20 11:47 1mo ago
2025-10-20 07:30 1mo ago
Starwood Property Trust: A 10.4% Dividend Yield And A Dip stocknewsapi
STWD
Analyst’s Disclosure:I/we have a beneficial long position in the shares of STWD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2025-10-20 11:47 1mo ago
2025-10-20 07:31 1mo ago
Cleveland-Cliffs Wants Into the Rare Earths Game. The Stock Jumps. stocknewsapi
CLF
Earnings take a back seat in Cleveland-Cliffs' third- quarter report: the steel maker desires to get into rare earths mining.
2025-10-20 11:47 1mo ago
2025-10-20 07:31 1mo ago
Horizon Copper Closes Arrangement with Royal Gold stocknewsapi
HNCUF
, /PRNewswire/ - Horizon Copper Corp. (TSXV: HCU) (OTCQB: HNCUF) ("Horizon Copper", "Horizon", or the "Company") is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement") with Royal Gold, Inc. ("Royal Gold") and International Royalty Corporation, a wholly-owned Canadian subsidiary of Royal Gold ("AcquireCo"), whereby Royal Gold indirectly through AcquireCo acquired all of the issued and outstanding Horizon shares (other than those held by Sandstorm Gold Ltd. ("Sandstorm")) (the "Horizon Shares") and through Horizon acquired all of the outstanding Horizon warrants (the "Horizon Warrants) (together the "Horizon Transaction").

As previously announced, pursuant to the Arrangement, holders of Horizon Shares ("Shareholders") are entitled to receive C$2.00 for each Horizon Share held and holders of Horizon Warrants ("Warrantholders") are entitled to receive C$2.00 less the applicable exercise price, per underlying share, for the Horizon Warrants held (the "Consideration").

The Company expects the Horizon Shares will be delisted from the TSX Venture Exchange effective at the close of business on Tuesday, October 21, 2025. Horizon will also apply to the Canadian securities regulators for the Company to cease to be a reporting issuer in the applicable jurisdictions.

For a more detailed description of the Arrangement, including regulatory matters and approvals, please see the Company's Notice of Meeting and Management Information Circular dated September 8, 2025 (the "Circular"), available under the Company's profile on SEDAR+ at www.sedarplus.ca.

Shareholders and Warrantholders are reminded to review the Circular in respect of the procedure for receiving the Consideration for their Horizon Shares and Horizon Warrants. Registered Shareholders and registered Warrantholders (Horizon Shares or Horizon Warrants held in physical form or a direct registration system (DRS) advice, as applicable) must complete, sign and return the applicable letter of transmittal (and in the case of Horizon Shares, also send their share certificate(s) or DRS advice(s)) to Computershare Investor Services Inc., the depositary for the Arrangement. Non-registered Shareholders and Warrantholders (Horizon Shares or Horizon Warrants held with a broker, bank or other intermediary) should contact their intermediaries for instructions and assistance in receiving the Consideration for such Horizon Shares or Horizon Warrants.

While the Canada Post strike is ongoing, registered Shareholders and Warrantholders who wish to deposit their letters of transmittal, Horizon Share certificates and other required documentation, as applicable, should use courier services or hand deliver such documentation to the depositary, Computershare Investor Services Inc., at 320 Bay Street, 14th Floor, Toronto, Ontario M5H 4A6.

If any Shareholder or Warrantholder has questions regarding the procedures for receiving the Consideration for their Horizon Shares or Horizon Warrants, as applicable, please contact Computershare Investor Services Inc., at 1-800-564-6253 (North America toll free) or 1-514-982-7555 (outside North America), or by email at [email protected].

Cautionary Note Regarding Forward-Looking Information

This press release contains forward-looking information within the meaning of Canadian securities laws. Forward-looking statements generally include, but are not limited to, statements with respect to management's beliefs, plans, estimates and intentions, and similar statements concerning the Horizon Transaction, the delisting of the Shares from the TSX Venture Exchange following completion of the Arrangement, the filing of the application to cease to be a reporting issuer in the applicable jurisdictions following completion of the Arrangement, the procedures for receiving the Consideration and the expected benefits to Horizon and its securityholders, and any other statements that are not historical facts. Although Horizon believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking information is typically identified by words such as: "believe", "expect", "anticipate", "intend", "estimate", "postulate" and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by Horizon is not a guarantee of future results or performance and that actual results may differ materially from those in forward-looking information as a result of various factors, including, but not limited to: the processes relating to the delisting of the Shares from the TSX Venture Exchange and the filing of the application to cease to be a reporting issuer in the applicable jurisdictions following completion of the Arrangement, any risks associated with the procedures for receiving the Consideration, the failure to realize the expected benefits of the Horizon Transaction; and other risks and uncertainties affecting Horizon. The forward-looking statements contained in this press release are made as of the date of this press release. Horizon disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. The securities referred to in this press release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. The Company assumes no obligation to update forward-looking statements except as required under securities laws. Further information concerning risks, assumptions and uncertainties associated with forward-looking statements and our business can be found in Horizon's Annual Information Form for the year ended December 31, 2024, filed under the Company's profile on SEDAR+ (www.sedarplus.ca), as well as subsequent filings that can also be found under the Company's profile.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Horizon Copper Corp.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In
2025-10-20 11:47 1mo ago
2025-10-20 07:32 1mo ago
Blaqclouds, Inc. Applies for FinCEN Registration as a Money Services Business (MSB) and Initiates Share Audit Following Management Transition stocknewsapi
BCDS
Robesonia, PA, October 20, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Blaqclouds, Inc., a Nevada corporation (OTC: BCDS), today announced that it has officially submitted its application to the U.S. Department of the Treasury’s Financial Crimes Enforcement Network (FinCEN) to register as a Money Services Business (MSB) under the Bank Secrecy Act (BSA). While the application has been formally accepted, the company anticipates receiving its BSA ID within the next two weeks, marking a major milestone in its pursuit of full regulatory compliance and financial transparency.

“Registering as a Money Services Business with FinCEN represents a critical step forward in aligning our Web3 payment technologies with existing U.S. compliance frameworks. This filing allows us to continue building decentralized financial infrastructure with the safeguards expected of regulated institutions.”

Shannon Hill, CEO of Blaqclouds, Inc.
Initiation of Share Audit and Legal Review Post-Management Change

In conjunction with the FinCEN filing, Blaqclouds has also launched a comprehensive audit of all common stock transactions and share issuances that occurred during the period of April 2025 through October 7, 2025. This action follows the re-acquisition of control of the company by new management on October 7, 2025, a turning point for the integrity and strategic direction of Blaqclouds.

Key audit details include:

The original acquisition of Blaqclouds occurred in November 2024, at which time the total outstanding share count was fewer than 400 million shares, of which the prior CEO personally held 250 million shares.
During the disputed period between April and October 2025, the previous CEO:

Canceled their own 250 million common shares,
Increased the authorized share count to 1 billion shares, and
Issued over 650 million shares through alleged 3rd-party debt conversions.

During the Company’s initial review, it was determined that two Notices of Conversion—each resulting in the issuance of 87 million shares, totaling 174 million shares—may have been executed without valid legal authority. The Company has formally notified its transfer agent to begin the process of investigating and correcting these irregularities.

“We need to determine if these actions were taken with proper shareholder approval, legal board authorization, and required public disclosure. Our legal team is currently reviewing all associated instruments and has been instructed to initiate cancellations and pursue litigation, if necessary, to safeguard the integrity of our capital structure and protect the interests of our legitimate shareholders.”

Shannon Hill, CEO of Blaqclouds, Inc.
Commitment to Transparency and Compliance

Dominion Stock Transfer is Blaqclouds’ official transfer agent and is working closely with the Company to reconcile and validate all share issuances during the disputed period. Once the audit is complete, the company will publicly disclose the findings and update its shareholder records accordingly.

With the FinCEN MSB registration process underway and a thorough legal and financial review in progress, Blaqclouds continues to demonstrate its commitment to operating as a trustworthy and fully transparent Web3 financial services company.

About Blaqclouds, Inc.

Blaqclouds bridges legacy finance with decentralized networks, creating seamless, real-world blockchain solutions that unify commerce and payments. Its mission is to make spending crypto as easy, trusted, and useful as cash.

Flagship consumer applications include:
– ShopWithCrypto.io – Crypto-to-gift card commerce
– ZEUSxPay.io – Web3 payment infrastructure
– DEX.ZEUSx.io – EVM-native decentralized exchange
– ApolloWallet.io – Secure, consumer-grade blockchain wallet

A full list of Blaqclouds WY and NV platforms can be found at: www.blaqclouds.io

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve certain risks and uncertainties that may cause actual results to differ materially. Blaqclouds, Inc. assumes no obligation to update or revise any forward-looking statements.

Media Contact
Blaqclouds, Inc.
c/o theAlley.io
Email: [email protected]
Phone: 307-323-4430
Website: www.blaqclouds.io

Source: Blaqclouds, Inc
2025-10-20 11:47 1mo ago
2025-10-20 07:36 1mo ago
5 Best-Performing ETF Areas of Last Week stocknewsapi
AMDW BITI CNRG EWY KRE XSD
Wall Street was upbeat last week, with the S&P 500 advancing 1.7%, the Dow Jones rallying 1.6% and the Nasdaq Composite rising 2.1%. Among key developments, signs of a regional banking crisis sent ripples through the market in the latter part of the week, but it soon recovered and posted gains to close out the week. Notably, the S&P 500 logged its best week since August, per MarketWatch.

Investors should note that U.S. regional bank stocks tumbled on Oct. 16, 2025, due to fresh signs of credit stress in the banking sector. Zions Bancorporation plunged 13% on that day and Western Alliance Bancorporation fell nearly 10% after both disclosed losses tied to troubled business loans.SPDR S&P Regional Banking ETF (KRE - Free Report) lost 6.2% on Oct. 16, 2025. However, the ETF KRE tacked on 1.6% gains on Oct. 17, 2025, suggesting strong levels of market complacency.

Meanwhile, the U.S. government shutdown dragged on. The shutdown is now the third-longest funding lapse in history (per CBS News).U.S.-China trade tensions also lingered. Trump announced that the United States would impose an additional 100% tariff on Chinese goods starting Nov. 1 in response to Beijing’s plan to introduce export controls on rare earth minerals.

However, investors probably cheered President Donald Trump's recent remarks thatthe threatened high tariffs on Chinese goods were “not sustainable," as quoted on Yahoo Finance. Over the last week, relations between the two countries have soured, though both sides have sent mixed signals about the outcome of the dispute.

Winning ETF Areas in FocusAgainst this backdrop, below we highlight a few winning exchange-traded fund (ETF) areas of the last week.

Inverse Bitcoin

ProShares Short Bitcoin ETF (BITI - Free Report) - Up 7.5% Last Week

Bitcoin prices lost about 4% last week as risk-on sentiments wavered occasionally. AI bubble fears have dominated Wall Street in recent weeks. Although tech stocks stayed steady, high-risk investments like Bitcoin failed to hold on to the winning momentum.

South Korea

iShares MSCI South Korea ETF (EWY - Free Report) - Up 6.2% Last Week

South Korean stocks have been in a good shape lately, supported by optimism over the U.S.-Korea trade progress. Talks between South Korean and U.S. officials on shipbuilding cooperation under the July trade deal lifted sentiment for industrial and export stocks, per Tradingeconomics. Confidence was also boosted by Samsung Electronics’ $110-million investment in U.S. biotech firm Grail to expand its AI healthcare reach, according to Tradingeconomics.

Semiconductors

SPDR S&P Semiconductor ETF (XSD - Free Report) - Up 4.7% Last Week

Semiconductor stocks have been the biggest beneficiaries of the AI boom. Chips facilitate data processing and model training at a massive scale. The more efficient the chips are, the faster and smarter the AI applications become. Recently, big semiconductor companies inked back-to-back big-ticket deals with AI companies, which has probably boosted ETFs like XSD.

Advanced Micro Devices ETFs

Roundhill AMD WeeklyPay ETF (AMDW - Free Report) - Up 4.5% Last Week

The AMDW ETF seeks to pay weekly distributions and to provide calendar week returns, before fees and expenses, that correspond to 1.2 times the calendar week total return of common shares of Advanced Micro Devices, Inc. (AMD - Free Report) .

AMD shares gained about 6% last week. AMD has been signing big AI deals lately. After it signed a notable deal with ChatGPT-maker OpenAI, the company has secured a significant order from Oracle for its upcoming MI450 chips, strengthening its position to challenge NVIDIA in the fast growing AI processor market, per Bloomberg, as quoted on Yahoo Finance.

Clean Power

SPDR S&P Kensho Clean Power ETF (CNRG - Free Report) - Up 3.5% Last Week

The underlying S&P Kensho Clean Power Index of the ETF CNRG is comprised of U.S.-listed equity securities of companies domiciled across developed and emerging markets worldwide which are included in the Clean Power sector.

Easing policy concerns related to alternative energy in the United States, the massive demand for energy amid the AI boom, cheaper valuation and the ongoing U.S. monetary policy easing have been driving the clean energy space.
2025-10-20 11:47 1mo ago
2025-10-20 07:39 1mo ago
Entain: Fresh chatter over MGM's next move stocknewsapi
GMVHF GMVHY
Could MGM Resorts International (NYSE:MGM) be limbering up for another tilt at Entain PLC (LSE:ENT)?

The question has resurfaced after a series of moves by the US casino group that look, at least on paper, like balance-sheet preparation.

Back in January 2021, MGM tried to buy Entain with an all-share offer worth £13.82 a share, a 22% premium to the closing price at the time.

Entain’s board swiftly rejected the proposal, saying it “significantly undervalued the company”. Since then, investors have kept one eye on whether MGM might return to the table.

Now, there is renewed speculation. On 15 October, MGM scrapped its $2.3 billion bid for a New York casino licence.

A day later, it agreed to sell the operations of MGM Northfield Park in Ohio for $546 million in cash, generating about $420 million in net proceeds. The timing has not gone unnoticed.

Citi analysts suggest these moves could be part of a broader effort to build financial flexibility ahead of a second approach for Entain or its joint venture, BetMGM.

But they add that an all-cash bid looks unlikely without MGM raising substantial new capital, meaning any fresh offer would probably have to be part-funded with shares.

A partial transaction focused solely on BetMGM also appears complex, given MGM’s current liquidity. For now, the market will have to settle for the familiar rumour cycle that has followed both companies since the first bid.

The shares were unmoved by the speculation at 814.6p.
2025-10-20 11:47 1mo ago
2025-10-20 07:40 1mo ago
Adaptimmune Announces Delisting from Nasdaq stocknewsapi
ADAP
October 20, 2025 7:40 AM EDT | Source: Adaptimmune Therapeutics PLC
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - October 20, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP) ("Adaptimmune" or the "Company") today announced that the Company's Board of Directors (the "Board") has determined to initiate the delisting of its American Depositary Shares ("ADSs"), each representing six ordinary shares, from The Nasdaq Capital Market ("Nasdaq") and deregistration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act").

Adrian Rawcliffe, Adaptimmune's Chief Executive Officer: "As we noted previously, the transaction with USWM CT, LLC, a subsidiary of US WorldMeds Partners, LLC (collectively, "US WorldMeds") followed an extensive review of strategic alternatives and represented the best path forward for Adaptimmune, our patients and other stakeholders. Since closing the transaction on July 31, 2025, we have been restructuring to support the assets transferred to US WorldMeds, and have continued our efforts to maximize value from our remaining assets including programs targeting PRAME and CD70. The delisting from Nasdaq and deregistration should facilitate cost reductions and further support our goal to maximize value going forward."

As previously reported by the Company, the Company received a written notice on September 22, 2025, from the Nasdaq Hearings Panel (the "Panel") confirming that the Company had been granted an exception period to regain compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the "Bid Price Rule"). The Company had until December 1, 2025 to regain compliance with the Bid Price Rule. Failure to regain compliance by December 1, 2025 would result in the delisting of the Company's ADSs from Nasdaq.

On October 16, 2025, the Company notified The Nasdaq Stock Market, LLC, pursuant to authorization by the Board on October 15, 2025, that it intends to file a Form 25 with the U.S. Securities and Exchange Commission (the "SEC") on or about October 28, 2025 to effect the voluntary delisting of the Company's ADSs from Nasdaq and to deregister the ADSs under Section 12(b) of the Exchange Act. Following confirmation by The Nasdaq Stock Market, LLC on October 17, 2025, the Company currently expects that the trading of its ADSs on Nasdaq will be suspended following the closing of trading on Nasdaq on or about October 27, 2025.

Following the delisting, any trading in the Company's ADSs would only occur in privately negotiated sales and potentially on an over-the-counter market. The Company currently expects that its ADSs will be quoted on the OTC Pink Limited Market, a market operated by OTC Markets Group Inc. (an "OTC market"), so that a trading market may continue to exist for its ADSs. There is no guarantee, however, that a broker will continue to make a market in the ADSs and that trading of the ADSs will continue on an OTC market or otherwise.

Ninety days after the date of filing of the Form 25, the deregistration of the Company's ADSs under Section 12(b) of the Exchange Act is expected to become effective. Following the delisting of the Company's ADSs from Nasdaq, the Company intends to file a Form 15 with the SEC certifying that it has fewer than 300 shareholders of record, upon which the Company's filing obligations under the Exchange Act will immediately be suspended, including the obligations to file all periodic reports.

The Board believes that the decision to delist the ADSs from Nasdaq and deregister and suspend the Company's reporting obligations under the Exchange Act is in the best interests of the Company and the holders of its ordinary shares and ADSs. As the Company continues with its efforts to maximize value from its remaining assets, the Board has determined that the burdens associated with operating as a registered public company listed on Nasdaq outweigh any advantages to the Company and the holders of its ordinary shares and ADSs. The Board's decision was based on careful review of numerous factors, including the potential for eliminating the significant costs associated with preparing and filing periodic reports with the SEC and the legal, audit and other expenses associated with being a public reporting company listed on Nasdaq, as well as the substantial costs and demands on management's time under the Sarbanes-Oxley Act of 2002, SEC rules and Nasdaq listing standards.

About Adaptimmune
We are a biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. In August 2024, the U.S. Food and Drug Administration ("FDA") approved our first biologics license application ("BLA") for TECELRA® (afamitresgene autoleucel) ("TECELRA"), which is the first engineered T-cell therapy for the treatment of a solid tumor cancer approved in the U.S. In July 2025, TECELRA was acquired by US WorldMeds alongside letetresgene autoleucel ("lete-cel"), for people with synovial sarcoma and myxoid liposarcoma, in relation to which a commercial launch was planned for 2026. A third clinical candidate, uza-cel, and the collaboration with Galapagos related to that cell therapy was also assigned to US Worldmeds as part of the transaction. We are working to ensure a smooth transition of TECELRA, lete-cel and uza-cel to US WorldMeds. We have also developed certain pre-clinical assets including our PRAME directed T-cell therapy and our CD-70 directed TRuC therapy. We are looking for strategic options in relation to these assets.

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Exchange Act. Forward-looking statements address our expected future business, financial performance, financial condition, as well as the results of operations and often contain words such as "anticipate" "believe," "expect," "may," "plan," "potential," "will," and similar expressions. Such statements are based only upon current expectations of Adaptimmune. Reliance should not be placed on these forward-looking statements because they involve certain risks and uncertainties. Such risks and uncertainties could cause our actual results to differ materially from those indicated by such forward-looking statements, and include, without limitation: risks associated with, and the timing and effectiveness of, the Company's voluntary delisting from Nasdaq; the Company's plans with respect to the delisting and deregistration of its ADSs; uncertainties regarding eligibility for and timing of quotation on an OTC market; and the trading of the Company's ADSs following the voluntary delisting of the ADSs from Nasdaq. For a further description of the risks and uncertainties that could cause our actual results to differ materially from those expressed in these forward-looking statements, as well as risks relating to our business in general, we refer you to our Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended December 31, 2024, our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date the statements were made and we do not undertake any obligation to update such forward-looking statements to reflect subsequent events or circumstances.

Adaptimmune Contact

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271003
2025-10-20 11:47 1mo ago
2025-10-20 07:41 1mo ago
SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders stocknewsapi
SPRC
October 20, 2025 07:41 ET

 | Source:

SciSparc Ltd

TEL AVIV, Israel, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that its collaboration with Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind”) has led to the publication of a U.S. patent application by the United States Patent and Trademark Office. The patent relates to an innovative combination therapy of MEAI (5-methoxy-2-aminoindane) and N-Acylethanolamines, such as Palmitoylethanolamide (PEA), addressing binge behavior disorders.

The patent refers to multiple binge behaviors, including excessive alcohol consumption, eating disorders, tobacco use, compulsive shopping, and problematic sexual conduct. The combination leverages MEAI’s psychedelic properties to reduce impulsivity and reward-seeking, enhanced by PEA’s anti-inflammatory and neuroprotective effects, potentially offering a breakthrough in treating substance use and behavioral addictions without the risks associated with traditional interventions.

SciSparc-Clearmind collaboration, focusing on PEA-MEAI combinations for conditions such as alcohol use disorder, cocaine addiction, obesity, and depression. Preclinical data supports the therapy’s potential efficacy in mitigating binge episodes while preserving natural reward pathways.

About SciSparc Ltd. (Nasdaq: SPRC):

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc’s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the Company is currently engaged in the following drug development programs based on THC and/or non-psychoactive cannabidiol: SCI-110 for the treatment of Tourette Syndrome, for the treatment of Alzheimer's disease and agitation; and SCI-210 for the treatment of autism and status epilepticus. The Company also owns a controlling interest in a subsidiary whose business focuses on the sale of hemp seeds’ oil-based products on the Amazon.com Marketplace.

About Clearmind Medicine Inc. (Nasdaq: CMND) (FSE: CWY)

Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements. Clearmind’s intellectual portfolio currently consists of 19 patent families including 31 granted patents. For further information visit: https://www.clearmindmedicine.com

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, the Company is using forward looking statements when discussing the potential benefits and advantages of the new patent application, and that this proprietary combination has the potential to address: excessive alcohol consumption, eating disorders, tobacco use, compulsive shopping, and problematic sexual conduct. Since such statements deal with future events and are based on SciSparc’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of SciSparc could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading "Risk Factors" in SciSparc's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 24, 2025, and in subsequent filings with the SEC. Except as otherwise required by law, SciSparc disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise.

Investor Contact:
[email protected]
Tel: +972-3-6167055
2025-10-20 11:47 1mo ago
2025-10-20 07:41 1mo ago
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders stocknewsapi
CMND
Vancouver, Canada, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced the publication of a U.S. patent application by the United States Patent and Trademark Office (USPTO) for its innovative combination therapy of 5-methoxy-2-aminoindane (MEAI) and N-Acylethanolamines, such as Palmitoylethanolamide (PEA), addressing binge behavior disorders.

The patent application stems from Clearmind’s ongoing collaboration with SciSparc Ltd. (Nasdaq: SPRC). This therapy targets multiple binge behaviors, including excessive alcohol consumption binge eating, smoking, compulsive shopping, and problematic sexual conduct. The combination leverages MEAI’s neuroplastic properties to reduce impulsivity and reward-seeking behavior, which, together with PEA, has shown a synergistic pharmacological effect and therefore potentially offering a breakthrough in treating substance use disorders and addictions by presenting a more effective and safer treatment than those available today.

This publication builds on Clearmind’s intellectual property portfolio. The Company has filed 13 patents related to its collaboration with SciSparc, focusing on MEAI and N-Acylethanolamines combinations for conditions such as alcohol use disorder, cocaine addiction, obesity and weight loss, and depression. Preclinical data supports MEAI's efficacy in mitigating addictive behaviors while preserving normal natural reward pathways.

“The publication of this U.S. patent application represents yet another advancement in our mission to pioneer safe and effective, next-generation treatments for binge behaviors,” said Dr. Adi Zuloff-Shani, CEO of Clearmind. “By combining MEAI’s unique neuroplastic profile with PEA’s synergistic benefits, we’re aiming to address a significant unmet needs in addiction medicine. We believe that this strengthens our position as a leader in psychedelic therapeutics and paves the way for additional clinical development.”

About Clearmind Medicine Inc.

Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.

The Company’s intellectual portfolio currently consists of nineteen patent families including 31 granted patents. The Company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Shares of Clearmind are listed for trading on Nasdaq under the symbol "CMND" and the Frankfurt Stock Exchange under the symbol “CWY0.”

For further information visit: https://www.clearmindmedicine.com or contact:

Investor Relations
[email protected]

Telephone: (604) 260-1566
US: [email protected]

General Inquiries
[email protected]
www.Clearmindmedicine.com

Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses how the combination of MEAI and PEA potentially offers a breakthrough in treating substance use disorders and addictions by presenting a more effective and safer treatment than those available today, the Company’s mission to pioneer safe and effective, next-generation treatments for binge behaviors, its aim to address significant unmet needs in addiction medicine and additional clinical development.  The Company cannot assure that any patent will issue as a result of a pending patent application or, if issued, whether it will issue in a form that will be advantageous to the Company. Forward-looking statements are not historical facts, and are based upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management’s expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission (“SEC”), including, but not limited to, the risks detailed in the Company’s annual report on Form 20-F for the fiscal year ended October 31, 2024 and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Clearmind is not responsible for the contents of third-party websites.
2025-10-20 11:47 1mo ago
2025-10-20 07:41 1mo ago
Gold market analysis for October 20 - key intra-day price entry levels for active traders stocknewsapi
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another.

Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics.

Follow Jim daily on Kitco.com as he provides both AM and PM roundups and a daily Technical Special.
1 877 963-NEWS
jwyckoff at kitco.com
2025-10-20 11:47 1mo ago
2025-10-20 07:45 1mo ago
Prismo Metals Announces Private Placement and Ripsey Gold Project Overlimit Silver Assay Results stocknewsapi
PMOMF
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES

OR FOR DISSEMINATION IN THE UNITED STATES

Vancouver, British Columbia – TheNewswire - October 20th, 2025 – Prismo Metals Inc. (the “Company”) (CSE: PRIZ) (OTCQB: PMOMF) is pleased to announce a non-brokered private placement (the “Private Placement”) of 12.5 million units of the Company (“Units”) at an issue price of $0.10 per Unit for minimum gross proceeds of $1,250,000. Each Unit will consist of one common share in the capital of the Company (a “Share”) and one-half of one common share purchase warrant of the Company (each whole warrant, a “Warrant”). Each Warrant will entitle the holder to purchase one Share for a period of thirty-six (36) months from the date of issue at an exercise price of $0.175. The Warrants will contain an accelerated expiry clause (the “Acceleration Clause“). Pursuant to the Acceleration Clause, if the Shares of the Company close at or above $0.25 for ten (10) consecutive trading days on the Canadian Securities Exchange (“CSE“), then the Company may accelerate the expiry date of the Warrants by issuing a news release announcing the accelerated Warrant term, pursuant to which the Warrants will expire on the 30th calendar days after the date of such news release.

The Company intends to use the net proceeds of the Private Placement primarily for drilling at its Silver King project and for general corporate purposes. In August 2025, Prismo submitted a plan of operations for the drill program with the Forest Service in Arizona. The first phase of drilling at Silver King will consist of a minimum of 1,000 meters.

Dr. Craig Gibson, Chief Exploration Officer of Prismo commented: “This first phase is designed to test the upper half of the steeply dipping pipelike Silver King mineralized body as well as potentially mineralization adjacent to the dense stockwork that was the focus of historic mining. Follow up drilling will expand on the initial program based on the results and may include separate targets outside of the historic mining area, such as the polymetallic vein mentioned above. The discovery of the two mineralized veins and porphyry style mineralization has resulted in Prismo evaluating a larger drill program to test those targets.”

Dr. Gibson added: “We have also received the overlimit assays for silver for four samples from the Ripsey mine, which range from 132 to 224 g/t Ag. These results confirm the high-grade nature of the mineralization along the Ripsey vein, exposed at the surface and in underground workings over about 600 meters along strike.”

Click Image To View Full Size

Figure 1. Proposed drill pads for the Silver King project in the process of being permitted.

Figure 2. Cross section through the Silver King mine workings showing proposed drill holes (in black) to test the pipelike mineralized body (in red)

The Private Placement will also be made available to existing shareholders of the Company who, as of the close of business on October 18th, 2025, held Shares (and who continue to hold such Shares as of the closing date of the Private Placement), pursuant to the existing securityholder exemption set out in BC Instrument 45-534 – Exemption From Prospectus Requirement for Certain Trades to Existing Security Holders (the “Existing Securityholder Exemption”). The Existing Securityholder Exemption limits a shareholder to a maximum investment of CAD$15,000 in a 12-month period unless the shareholder has obtained advice regarding the suitability of the investment and, if the shareholder is resident in a jurisdiction of Canada, that advice has been obtained from a person that is registered as an investment dealer in the jurisdiction. If the Company receives subscriptions from investors relying on the Existing Securityholder Exemption exceeding the maximum amount of the Private Placement, the Company intends to adjust the subscriptions received on a pro-rata basis.

The Units issued pursuant to the Private Placement, and the Existing Securityholder Exemption will be subject to a four-month hold period from the closing date of the Private Placement under applicable Canadian securities laws, in addition to such other restrictions as may apply under applicable securities laws of jurisdictions outside Canada.

The Company may pay finder's fees to eligible finders in connection with the Private Placement, subject to compliance with applicable securities laws and Canadian Securities Exchange policies.

The securities being offered have not been and will not be registered under the U.S. Securities Act and may not be offered or sold in the United States, or to, or for the account or benefit of, U.S. persons or persons in the United States, absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

Ripsey Gold Project Overlimit Assay Results

The Company has also received the overlimit assays for silver for four samples from the Ripsey mine, ranging from 132 to 224 g/t Ag, announced October 16, 2025 (Table 1).  These results confirm the high-grade nature of the mineralization along the Ripsey vein, exposed at the surface and in underground workings over about 600 meters along strike.

Table 1. Assay results for samples taken of the Ripsey vein

 

Sample

Location

Easting

Northing

Width m

Au g/t

Ag g/t

Cu %

Pb %

Zn %

544101

East surface

502,639

3,651,725

1.5

2.98

60.40

1.62

0.01

0.23

544102

East surface

502,679

3,651,748

0.5

0.02

1.80

0.79

-

1.56

544103

East surface

502,745

3,651,782

1.0

0.79

3.82

-

0.24

0.24

544104

East tunnel

 
 

0.6

14.7

214

3.28

0.42

3.26

544105

East tunnel

 
 

0.7

3.24

82.39

1.69

0.21

5.11

544106

East tunnel

 
 

0.6

3.14

132

3.46

0.36

6.52

544107

East tunnel

 
 

0.8

3.05

223

4.85

0.71

7.83

544108

East tunnel

 
 

0.75

1.42

68.10

.30

0.16

3.39

544110

Main stope

502,320

3,651,688

1.5

2.66

57.53

.37

0.01

0.18

544111

Main stope

502,309

3,651,688

0.4

0.06

1.36

-

-

-

544112

Main shaft

502,288

3,651,688

0.75

14.6

148

0.60

0.20

0.18

544113

Vein HW

502,250

3,651,677

0.75

0.75

42.50

0.17

0.10

-

544114

Vein FW

502,250

3,651,677

0.75

0.11

5.10

-

-

-

544115

East Shaft

502,420

3,651,693

1.5

1.19

18.57

0.11

-

-

Qualified Person

Dr. Craig Gibson, PhD., CPG., a Qualified Person as defined by NI-43-01 regulations and Chief Exploration Officer and a director of the Company, has reviewed and approved the technical disclosures in this news release. Other than the sampling conducted by Dr. Craig Gibson as indicated herein, the data presented in this press release was obtained from public sources, should be considered incomplete and is not qualified under NI 43-101, but is believed to be accurate. The Company has not verified the historical data presented and it cannot be relied upon, and it is being used solely to aid in exploration plans.

About the Silver King

Discovered in 1875, the Silver King mine was one of Arizona’s most important historic producers, yielding nearly 6 million ounces of silver at grades of up to 61 oz/t.  The Silver King mine sits only 3 km from the main shaft of the Resolution Copper project — a joint venture between Rio Tinto and BHP and one of the world’s largest unmined copper deposits with an estimated copper resource of 1.787 billion metric tonnes at an average grade of 1.5% copper(1). The unique land position is fully surrounded by Resolution Copper’s claim block, offering strategic upside. Selected samples from small-scale production in the late 1990s returned grades as high as 644 oz/t silver (18,250 g/t) and 0.53 oz/t gold (15 g/t), indicating that high-grade mineralization remains.

(1)https://resolutioncopper.com/about-us/ 

About Prismo Metals Inc.

Prismo (CSE: PRIZ) is a mining exploration company focused on advancing its Silver King, Ripsey and Hot Breccia projects in Arizona and its Palos Verdes silver project in Mexico.

Please follow @PrismoMetals on Twitter, Facebook, LinkedIn, Instagram, and YouTube

Prismo Metals Inc.

1100 - 1111 Melville St., Vancouver, British Columbia V6E 3V6

Phone: (416) 361-0737

Contact:

Alain Lambert, Chief Executive Officer [email protected]

Gordon Aldcorn, President [email protected]  

Cautionary Note Regarding Forward-Looking Information

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or  variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things: the timing, costs and results of drilling at Silver King.

These forward‐looking statements involve numerous risks and uncertainties, and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things: delays in obtaining or failure to obtain appropriate funding to finance the exploration program at Silver King.

In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that: the ability to raise capital to fund the drilling campaign at Silver King and the timing of such drilling campaign.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
2025-10-20 10:47 1mo ago
2025-10-20 05:59 1mo ago
US Federal Reserve to Host Bitcoin and Crypto Payments Conference Tomorrow — What to Expect cryptonews
BTC
Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

The US Federal Reserve is set to make key decisions on digital assets during its Payments Innovation Conference on Tuesday, October 21. Leading personalities from the crypto and traditional finance sectors will be present at the event as investors wait to see what this might mean for the market.

What to Expect From the US Federal Reserve Crypto Conference
The US Fed conference was announced on September 3 in a bid to improve crypto regulations in the country. The meeting will focus on how emerging technologies are transforming the global payments landscape.

According to Governor Christopher J. Waller, who will open and close the event, the goal is to examine how innovation can improve both the “safety and efficiency” of payments while adapting to the changing needs of consumers and businesses.

Panel discussions will cover a broad range of topics. This includes bridging traditional finance with the digital asset economy, exploring stablecoin business models, and the integration of AI in payments. Another highly anticipated segment will examine tokenized financial products.

The meeting will feature senior executives from BlackRock, Franklin Templeton, Fireblocks, Chainlink, and BNY Mellon, who will share insights. 

FED MEETS CRYPTO 🔔

The Federal Reserve will host a Payments Innovation Conference on Oct 21, featuring panelists from Chainlink, Paxos, Circle, and Coinbase.

Traditional finance is finally sitting at the same table as CRYPTO. 🔥 pic.twitter.com/2QWlz6UiX2

— Wise Advice (@wiseadvicesumit) October 20, 2025

For the first time, the US Federal Reserve is openly engaging with industry leaders about Bitcoin, stablecoins, and tokenized assets. In essence, the discussions could lay the groundwork for how crypto payments are integrated into the U.S. financial system.

Trump-Era Policy Shift Opened Door for Fed’s New Crypto Outlook
Policy reforms under the Trump administration since inauguration have effectively reversed earlier restrictions discouraging banks from servicing crypto firms.

The US Federal Reserve also ended its supervisory program targeting digital-asset institutions and removed “reputational risk” flags that once limited their access to financial services.

Following the passage of the GENIUS Act in July, analysts say the environment for blockchain innovation has never been more favorable. These policy moves have laid the foundation for tomorrow’s conference, giving digital payments a clearer regulatory pathway.

The conference also comes at a critical moment for monetary policy. The Federal Open Market Committee (FOMC) will meet again on October 28–29. Markets are expecting another 25 basis point rate cut, lowering the federal funds rate to around 4%. The US Fed Reserve made its first rate cut of the year last month, due to the labor market and sluggish growth.

Governor Waller recently said that while inflation is easing, the effects of Trump’s tariffs have complicated the path forward. Another rate cut could inject liquidity into financial markets, potentially benefiting the crypto market.

Investment disclaimer: The content reflects the author’s personal views and current market conditions. Please conduct your own research before investing in cryptocurrencies, as neither the author nor the publication is responsible for any financial losses.

Ad Disclosure: This site may feature sponsored content and affiliate links. All advertisements are clearly labeled, and ad partners have no influence over our editorial content.
2025-10-20 10:47 1mo ago
2025-10-20 06:00 1mo ago
Ethereum And Solana Flash ‘W Bottoms': Bollinger Returns With Legendary Call cryptonews
ETH SOL
John Bollinger, the inventor of Bollinger Bands and a figure whose occasional crypto market calls carry outsized weight, says Ethereum and Solana are tracing potential “W” bottoms—while Bitcoin is not. In a post on X on October 18, Bollinger wrote: “Potential ‘W’ bottoms in Bollinger Band terms in ETHUSD and SOLUSD, but not in BTCUSD. Gonna be time to pay attention soon I think.”

Potential ‘W’ bottoms in Bollinger Band terms in $ETHUSD and $SOLUSD, but not in $BTCUSD. Gonna be time to pay attention soon I think.

— John Bollinger (@bbands) October 18, 2025

Ethereum And Solana Price: What To Watch Now
The emphasis on “Bollinger Band terms” is doing heavy lifting here. In classic Bollinger taxonomy, a W bottom is a two-trough reversal with the second low holding above the first, often accompanied by a volatility signature that includes a prior band expansion, subsequent contraction, and a failure to register a lower low at the bands on the second leg.

The more robust versions see the second low forming inside the bands or with a positive divergence against the lower band, followed by a band “pinch” and a move through the middle band that transitions into an upper-band walk. Bollinger’s phrasing—“potential” and “time to pay attention”—signals that, in his framework, pattern recognition precedes confirmation, and that the validation trigger lies in subsequent price interaction with the middle and upper bands rather than in the raw shape of the price lows alone.

The rarity of Bollinger’s crypto commentary layered urgency onto the signal. As crypto trader Satoshi Flipper (@SatoshiFlipper) stressed, “John Bollinger, creator of Bollinger Bands, makes barely 1 crypto call per year and hasn’t made one for ETH in 3 years until yesterday. And each call he makes goes on to mark generational bottoms. He just told us SOL + ETH have bottomed, now imagine fading this legend.”

The same account detailed that Bollinger’s last notable Ethereum call dates to September 9, 2022, noting that ETH “went on to pump from $1,290 to $4,000.” That historical reference captures the prevailing market psychology: Bollinger’s infrequent, technically disciplined alerts are perceived by many traders as cycle-defining.

Context from earlier this year also helps frame the setup. On April 10, Bollinger publicly flagged a similar structure in Bitcoin, saying: “Classic Bollinger Band W bottom setting up in BTCUSD. Still needs confirmation.” In the exact same week, BTC carved out a bottom at $74,508 and proceeded to log seven straight green weekly candles, advancing roughly 55%. From Bollinger’s call into the first week of October, BTC rallied more than 70%.

The market nuance in Bollinger’s latest readout is the explicit exclusion of Bitcoin. If ETHUSD and SOLUSD are printing W-like structures in Bollinger terms while BTCUSD is not, it implies a temporary decoupling in volatility structure and relative strength. In practical terms, a non-confirming Bitcoin can either lag into a later confirmation, remain range-bound in a mid-band churn, or fail its own setup if lower-band interactions persist without recapture of the middle band.

For Ethereum and Solana, confirmation would typically look like sustained closes above the 20-period moving average (the Bollinger middle band), followed by a disciplined advance that converts the upper band from resistance into a guide. A healthy W bottom sequence tends not to produce immediate, vertical band overthrows; rather, it builds a stair-step profile with periodic mid-band checks that hold.

Failure would involve another lower-band excursion that undercuts the second trough or a volatility bloom that widens the bands without directional follow-through—both signatures of an incomplete base.

At press time, ETH traded at $4,037.

ETH price, 1-day chart | Source: ETHUSDT on TradingView.com
Featured image created with DALL.E, chart from TradingView.com
2025-10-20 10:47 1mo ago
2025-10-20 06:01 1mo ago
BlackRock Launches First Bitcoin ETP on London Stock Exchange After FCA Ban Lift cryptonews
BTC
BlackRock (BLK), the world’s largest asset manager, has launched its first bitcoin exchange-traded product (ETP) in the United Kingdom, marking a major milestone for crypto investment in traditional markets. The iShares Bitcoin ETP (IB1T) began trading on the London Stock Exchange (LSE) on Monday, following the Financial Conduct Authority’s (FCA) decision to lift its long-standing ban on certain bitcoin-based ETPs.

The new product allows retail investors to gain regulated exposure to bitcoin (BTC), priced at around $110,984.37, without needing to directly hold the cryptocurrency. The IB1T ETP is already listed on several major European exchanges, including Xetra, Euronext Amsterdam, and Euronext Paris, where it debuted earlier this year in March.

BlackRock’s expansion into the U.K. crypto market highlights the growing acceptance of digital assets among institutional and retail investors. The asset manager, overseeing over $13 trillion globally, continues to lead the charge in regulated bitcoin investment options. Its U.S.-listed iShares Bitcoin Trust (IBIT) currently holds $85.5 billion in net assets, making it the world’s largest spot bitcoin ETF. Fidelity’s FBTC follows with $21.9 billion in assets, according to SoSoValue data.

Meanwhile, Swiss-based 21Shares also entered the U.K. market, introducing four of its flagship crypto exchange-traded notes (ETNs) for retail investors. These include bitcoin (ABTC) and ether (AETH) staking products, along with two low-fee options—CBTC and ETHC—featuring management fees of just 0.10%.

Russel Barlow, CEO of 21Shares, hailed the FCA’s policy shift as “a landmark step for the U.K. market,” emphasizing that it finally gives everyday investors access to regulated crypto investment vehicles.

In its first hour of trading, the IB1T ETP recorded a volume of 1,000 shares, signaling strong early interest from investors eager to tap into bitcoin’s growing mainstream appeal.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>
2025-10-20 10:47 1mo ago
2025-10-20 06:05 1mo ago
Shiba Inu (SHIB): Not Adding Zero, Price Takes U-Turn cryptonews
SHIB
Mon, 20/10/2025 - 10:05

Despite the deleted zero, the Shiba Inu meme coin is still under threat due to whale sales and a rare bearish pattern.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Popular meme cryptocurrency Shiba Inu or, as it better known, SHIB, has managed to dodge what its enthusiasts feared most — being stuck with another zero in its price. 

After a brutal "Black Friday" sell-off on Oct. 10, the meme coin dipped to below $0.00001 zone, but it was not for long, as the next week, SHIB already managed to find short-term footing around $0.0000102.

But, and it is a big one, the problem is that nothing really changed. Shiba Inu coin is still sitting 70% below where it was last December, with a market cap now around $6.9 billion, and whales keep dumping. At the start of the week their wallets had about 21 billion SHIB but now close to 92 billion.

HOT Stories

SHIB/USD by TradingViewExchange balances also went up — 276 trillion tokens compared to 275 trillion on Sunday. So, coins are still being moved to sell.

SHIB price prints bearish patternThe hidden bearish signal, as usual, is in the price chart, as the ominous pattern — a descending triangle — with the floor at $0.00001052, was tested in April, June and again during the October crash. That is a classic break and retest setup, which usually points lower, and if it plays out, SHIB can go straight to $0.000006.

Right now, buyers managed to hold the line and avoid the zero. But whales are still selling, on-chain numbers are down and the chart is ugly. The bounce might not last long.

Related articles
2025-10-20 10:47 1mo ago
2025-10-20 06:05 1mo ago
BlackRock Lists Bitcoin ETP in UK, Expanding Retail Access to BTC cryptonews
BTC
2 mins mins

In Brief

BlackRock lists physically backed Bitcoin ETP on London Stock Exchange.

UK retail investors gain BTC exposure through traditional trading accounts.

Bitcoin rebounds 4.23% in 24h, trading above $110K after recent volatility.

BlackRock has listed its iShares Bitcoin ETP (IB1T) on the London Stock Exchange, targeting retail investors in the UK. This marks the first time UK-based traders can gain direct Bitcoin exposure through traditional brokerage accounts.

The ETP is fully backed by physical Bitcoin held via Coinbase, eliminating the need for users to manage wallets or private keys. At the end of each trading day, all assets are secured in cold storage under institutional-grade custody protocols.

BlackRock launched the product to meet growing UK crypto demand, which has grown at a 12% annualised rate since 2022. The firm projects UK crypto users could reach four million within a year as access improves.

Its latest People & Money report forecasts a 21% increase in new UK crypto investors over the next 12 months. IB1T is built on regulated infrastructure, offering Bitcoin exposure with enhanced security and compliance.

Bitcoin Price Rebounds as Institutional Momentum Grows
Bitcoin is currently trading at $110,895.73, showing a 4.23% gain over the past 24 hours despite a slight hourly pullback. This rebound follows recent market weakness and reflects growing confidence, possibly supported by institutional participation.

Bitcoin daily chart screenshot | Source: CoinMarketCap
However, Bitcoin remains down 3.56% on the weekly chart, signaling that recovery is not yet complete. Still, the current price action suggests consolidation and renewed momentum near resistance levels.

The BlackRock listing may drive further adoption by connecting traditional investors to Bitcoin through a regulated gateway. Analysts view this development as a key moment in bridging conventional finance with digital assets.

BlackRock’s move adds to ongoing institutional trends, with broader interest expanding across Ethereum and other crypto assets. If momentum continues, Bitcoin could test higher resistance as investor sentiment strengthens.

DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.

Rate this post
2025-10-20 10:47 1mo ago
2025-10-20 06:05 1mo ago
STBL Sell-Off Sparks Insider Trading Allegations and Market Panic cryptonews
STBL
STBL has plunged over 80% since launch, with $17 million in alleged insider-linked sell-offs fueling a sharp market backlash.The team denies involvement, pledging transparency and a Q4 repurchase plan despite plans to mint 100 million USST.Analysts see a possible accumulation zone near $0.10, but warn recovery hinges on volume and renewed investor trust.STBL has lost 80% of its value from its peak, plunging the token into a significant decline. Additionally, the token is now mired in controversy as the founding team faces accusations of selling off millions of dollars’ worth of tokens.

Meanwhile, the project is moving forward with plans to mint 100 million USST and launch a repurchase program by the end of October. This development has divided the market between hopes of recovery and fears of collapsing trust.

Sponsored

Sponsored

Who Sold — and Why Did the Market React So Sharply?Within just a month of its launch, STBL, the token of the stablecoin protocol of the same name, has plunged more than 80% in value. Data from BeInCrypto shows that STBL hit an all-time high around $0.60, then dropped to a low of about $0.0797 before recovering slightly to $0.11478. At this price, STBL’s market cap hovers near $58 million.

STBL price performance. Source: BeInCryptoAccording to Bubblemaps, on-chain data revealed that at least five large addresses sold all of their STBL holdings, pocketing roughly $17 million in profits. Notably, these same five addresses were linked to early STBL trading activity in September — when they collectively earned over $10 million during the token’s launch phase.

STBL sell trades by 5 major traders. Source: BubblemapsThis pattern has sparked speculation within the crypto community about potential insider trading or coordinated sell-offs. Some X users described these accounts as “snipers,” implying algorithmic or insider-led operations rather than normal market participants.

“I don’t like these snipers; they could be insiders or maybe not, but they’ve dragged my $STBL portfolio deep underwater. Anyway, luckily, the bastard is out, and I still have enough stablecoin outside to buy some more at the current bottom,” one trader wrote.

Sponsored

Sponsored

While some observers labeled the sellers as casual traders, STBL’s CEO Avtar Sehra pushed back, asserting these were “orchestrated and professional accounts,” citing the Bubblemaps findings.

STBL’s team has publicly denied any internal involvement in the sell-off. In a statement, they emphasized that treasury operations remain transparent and that no team allocations or vesting schedules have changed:

“We’re focused on building the protocol and adoption with the community. Allocations/vesting are unchanged. Furthermore, any tokens vesting this quarter won’t be minted and will not enter circulation.” STBL shared.

Despite the turmoil, STBL announced its intention to mint 100 million USST in Q4. The move raised concerns that an increased token supply could add further selling pressure, especially amid shaken investor confidence. Previously, as BeInCrypto reported, the STBL team also said that they will open a USST repurchase and staking program at the end of October, aiming to restore liquidity and stabilize the token value.

Technical Analysis: Accumulation Zone or Dead-Cat Bounce?According to crypto analyst Michaël van de Poppe, the current price action may represent a key accumulation phase, as STBL forms a technical bottom near $0.09–$0.10. He suggests that if sentiment improves, the token could rebound toward the $0.17–$0.20 resistance range — previous support levels now flipped into resistance.

STBL price analysis. Source: Michaël van de PoppeHowever, Michaël van de Poppe also cautioned that a sustained uptrend can only occur if market volume recovers and fresh capital returns to the project. Until then, STBL’s fate remains uncertain — teetering between a cautious rebound narrative and the shadow of a credibility crisis.

Disclaimer

In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.
2025-10-20 10:47 1mo ago
2025-10-20 06:06 1mo ago
21Shares, Bitwise and WisdomTree open UK retail access to Bitcoin and Ethereum ETPs following FCA approval cryptonews
BTC ETH
The Financial Conduct Authority, the UK's financial regulator, officially lifted a four-year retail ban on crypto ETNs earlier this month.
2025-10-20 10:47 1mo ago
2025-10-20 06:06 1mo ago
Bitcoin's time to shine officially begins: BTC to $150K next? cryptonews
BTC
Bitcoin (BTC) is entering its most historically bullish period of the year, with data showing that late October through early November has delivered the highest probability of positive returns over the past decade.

A 10-year seasonality analysis indicates that Bitcoin has recorded gains in up to 90% of instances during this timeframe, according to insights shared by charting platform TrendSpider. 

Bitcoin seasonality chart. Source: TrendSpider
This pattern has often preceded major rallies, including the strong uptrends seen in 2017 and 2020, as investor sentiment and liquidity typically strengthen heading into year-end.

Market observers note that Bitcoin’s seasonal trend aligns with the ongoing consolidation phase around the $110,000 spot, suggesting conditions could be favorable for another leg higher.

The pattern held true in 2024, when Bitcoin surged past $100,000 for the first time, fueled by spot ETF inflows, renewed institutional demand, and growing regulatory optimism following the re-election of Donald Trump, who has been viewed as friendly to the cryptocurrency sector.

The rally extended into 2025, with the cryptocurrency reaching new record highs above $117,000 earlier this year.

Currently, Bitcoin is trading around $110,000, consolidating after months of volatility. Analysts view this pause as a potential setup for another breakout.

Indeed, after hitting a record high above $125,000, Bitcoin retreated amid growing trade tensions between the United States and China.

Bitcoin’s key price levels to watch 
From a technical perspective, analysis by Ted Pillows in an X post on October 20 observed that Bitcoin has regained a critical support zone between $109,000 and $110,000, signaling renewed buyer strength after recent volatility.

Pillows noted that the next key resistance lies at $112,000, a level that, if reclaimed, could pave the way for a broader rally toward the mid-$110,000s and potentially higher. 

$BTC has reclaimed the $109,000-$110,000 support zone.

The next crucial level to reclaim is $112,000, which could push Bitcoin higher.

With US-China trade tensions easing, I think BTC could rally more from here. pic.twitter.com/D8VNses1ix

— Ted (@TedPillows) October 20, 2025

He added that improving global risk sentiment appears to be aiding the move. With US-China trade tensions showing signs of easing, investor confidence in risk assets, including cryptocurrencies, has strengthened, fueling speculation that Bitcoin could extend its recovery in the coming sessions.

Bitcoin price analysis
By press time, Bitcoin was trading at $110,864, up 3.6% in the past 24 hours but still down 3.7% over the past week.

Bitcoin seven-day price chart. Source: Finbold
Indeed, while the $110,000 support remains fragile, it is crucial, as maintaining it is key to pushing the asset toward the $115,000 resistance zone.

Featured image via Shutterstock
2025-10-20 10:47 1mo ago
2025-10-20 06:07 1mo ago
SUI gains steam on Canary's ETF filing update and SUIG's growth strategy cryptonews
SUI
SUI is capturing renewed attention as Canary advances its Spot SUI ETF filing and SUIG lays out ambitious plans to expand the Sui blockchain ecosystem.
2025-10-20 10:47 1mo ago
2025-10-20 06:07 1mo ago
Breaking: BlackRock Launches Bitcoin ETP For the UK Investors cryptonews
BTC
BlackRock, the world’s largest asset manager with over $13 trillion in assets, has officially launched its iShares Bitcoin Exchange-Traded Product (ETP) on the London Stock Exchange on October 20, 2025

The new product, trading under the ticker IB1T, gives UK retail investors their first-ever opportunity to gain direct exposure to Bitcoin through a regulated exchange-listed fund.

Unlike derivative-based products, the iShares Bitcoin ETP directly tracks Bitcoin’s spot price, giving investors a simple and transparent way to invest in the world’s largest cryptocurrency, without having to buy or store it themselves.

According to BlackRock, the iShares Bitcoin ETP is 100% physically backed by Bitcoin held in custody through Coinbase, ensuring security via multiparty computation and cold storage systems. 

The product’s introduction represents not only a regulatory milestone but also the rising institutional embrace of digital assets.​

Strong Regulatory Support from the UK FCAThe launch comes shortly after the UK Financial Conduct Authority (FCA) lifted its restrictions on crypto-linked ETPs. For the first time since 2021, UK retail investors can now legally access regulated Bitcoin products.

By taking this step, the UK joins other European markets like Germany and France, which have already embraced Bitcoin ETPs, signaling a more open stance toward digital asset innovation.

Institutional Momentum and UK Market GrowthGlobally, BlackRock’s crypto arm has seen huge success with its U.S.-based iShares Bitcoin Trust (IBIT), which holds over $85.5 billion in assets. With the UK launch, the firm aims to tap into rising demand from both retail and institutional investors amid renewed optimism in the crypto market.

Recent research cited by BlackRock projects a 21% rise in UK adults investing in crypto for the first time within the next 12 months, positioning the UK as Europe’s third-fastest-growing crypto market.​

As of now, Bitcoin is trading around $110,900, ​reflecting a jump of 3.3% seen in the last 24 hours with a market cap hitting $2.21 trillion.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.
2025-10-20 10:47 1mo ago
2025-10-20 06:10 1mo ago
Majority of institutions bullish on Bitcoin, says Coinbase survey cryptonews
BTC
Coinbase revealed that two-thirds of institutions expressed a positive outlook for Bitcoin over the next six months.